Overview 1:  Drug-related deaths in Ireland, 1990 to 2002. by Long, Jean & Lynn, Ena
Mr Noel Ahern, Minister of State with responsibility
for the National Drugs Strategy, launched the
strategy document of the North Eastern Regional
Drugs Task Force (NERDTF) – the first strategy to
be published by a regional task force – on 7 July
2005. This was in the same week that the minister
announced an allocation of €2.5 million to initiate
the action plans for six of the ten regional drugs
task forces. The NERDTF will receive €290,000 of
this allocation in addition to their existing
resources. 
The document presents strategic priorities to
address the problem of drug misuse in the region
identified through consultation with stakeholders
and communities.1 The NERDTF has estimated that
it will cost €2,350,000 annually for all the priority
actions to be implemented.
Some of the more important strategic interests are: 
■ A comprehensive approach to drug and alcohol misuse through the inclusion of alcohol in the terms
of reference for the regional drugs task force
■ A focus on prevention of substance misuse among the school-age population and their parents
■ A range of treatment and rehabilitation options for those with problem substance use to permit the
development of individualised care plans and treatment
■ A need to develop harm-reduction approaches to drug use, for example, needle-exchange schemes
and drop-in centres
■ A number of research priorities which include describing drug use among hidden populations and
developing quality standards for the services.
Mr Michael Mulvey, community representative for Co Cavan, welcomed all present to the launch. Ms Lesley
O’Sullivan, Health Service Executive representative on the NERDTF, described the consultation process,
which took place between April and September 2004. The participating agencies included community
organisations, special interest groups, young people and health professionals. Mr Pat Shields, Chairperson of
the NERDTF, reported that the needs of parents (of drug users) had largely been overlooked in the past and
the inclusion of their needs in prevention, treatment and rehabilitation activities in this strategy was timely. 
Mr Ahern said that the NERDTF strategy outlines the ‘profile of the drugs issue within the North-East,
identifies current services, highlights the gaps which exist in service provision and recommends priority
actions for future service planning and delivery’. He emphasised the need for wide community support for
prevention, treatment and rehabilitation activities in the region. He reported that it was important to attract
drug users to and retain them in treatment and stressed that drug-using profiles within communities
change and it was important that interventions were flexible enough to respond to such changes. 
Dr Nazih Eldin, interim co-ordinator for NERDTF, presented a review of a number of the recommendations
under the pillars of the National Drugs Strategy and showed how the NERDTF strategy aligned with them.
Dr Eldin called for the immediate appointment of a full-time co-ordinator and the immediate allocation of a
budget to facilitate the vital work identified by the group. (Siobhán Reynolds)
1. North Eastern Regional Drugs Task Force (2004) Regional Drugs Strategy 2005–2008. Navan, Co Meath: North Eastern
Regional Drugs Task Force.
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Because of the hidden nature of illegal drug use, a
time lag usually exists between the appearance of
a new trend in illegal drug use and the production
and dissemination of data about it. For example,
the first published accounts of ecstasy use
appeared in articles written in 1985 by journalists –
a decade before drug information agencies began
collecting and reporting data on ecstasy. 
In such circumstances, youth media have been
identified as a potentially valuable source for
monitoring emerging drug-use trends among
young people. To coincide with International Day
against Drug Abuse and Illicit Trafficking, the
European Monitoring Centre for Drugs and Drug
Addiction (EMCDDA) published a thematic paper,
Youth Media, on its website, which reports on a
study that tested the utility and validity of youth
media for this purpose.
Five EU member states – Finland, Greece, Ireland,
Portugal and the UK – collaborated in a voluntary
EMCDDA project, in which a total of 1,763 drug
references from 26 print magazines with large
circulations targeting mainstream young people
(aged 15–30 years) in the five countries were
collected between December 2001 and September
2002. Deborah Olszewski of the EMCDDA led the
project and the research into Irish youth media
was undertaken by DMRD staff member Brigid Pike
and student researcher Sandra Leibrand. 
The magazines were scanned for textual and visual
drug references. These references were coded and
analysed using quantitative methods, together with
selected descriptive texts to validate the coding and
to deepen understanding. The editors of the
magazines were interviewed about editorial practices
regarding the coverage of drugs issues. The six UK
and Irish youth magazines surveyed in the study
accounted for 61 per cent of the drug references.
The study concludes that youth lifestyle magazines,
which target readers with young ‘outgoing’
lifestyles who are interested in new trends and do
not condemn drug use as a matter of principle, are
a useful source for monitoring and triangulating
evidence of signs of early use of new drugs.
According to the study, youth media monitoring is,
moreover, a low-cost source of information as the
content analysis workload can be flexible and
carried out when researcher time allows. 
Overall, the three drugs most frequently mentioned
in the print media surveyed were cannabis, ecstasy
and cocaine, with 10 per cent of drug mentions
referring to combinations with alcohol. This reflects
the findings of epidemiological surveys, which
generally report relatively high prevalence estimates
of the use of cannabis, ecstasy and cocaine. Drugs
that are less commonly used (heroin, crack) were
mentioned less often.
The study also shows that youth media can
contribute to a deeper understanding of the nature
of emerging drug-use trends. Youth magazines are
more likely than mainstream magazines to cover
both the risks and benefits of cannabis and ecstasy
use. In contrast, they adopt a more proscriptive
approach to heroin and crack – focusing exclusively
on negative aspects in a broadly similar way to
mainstream newspapers and magazines.
Furthermore, the drug references that carry
messages about drugs and drug use give more or
less equal coverage to the positive and negative
aspects. The positive aspects of drug use most
frequently mentioned were the psychological and
relaxant effects, followed by increased physical
energy. On the negative side, the acute physical risks
of drug use, addiction and psychological problems
were mentioned more often than other risks. Ecstasy
was the drug most often mentioned in relation to
acute physical risk. Cannabis was the drug most
often mentioned in relation to psychological risk,
closely followed by alcohol and cocaine.
The study discusses a number of issues to be
considered in designing and conducting a youth
media monitoring project. There is a high turnover
of magazine titles, which makes it difficult to
monitor magazines over time and renders key
informants important as sources of up-to-date
advice on appropriate youth print media.
Magazines to be included in such a study should
have relatively large circulation figures, in order to
gain insights into the potential for widespread
diffusion of emerging drug trends by exploring
drug fashions and attitudes to drug use. Those
coding the drug references should be familiar with
street-level drug terms and culture as youth
magazines often refer to drugs by relatively allusive
or conjectural ‘street’ names or in picture formats.
In analysing the data, regard should be had to the
legal controls exerted over the way drugs may be
covered in the national magazine industry. For
example, in Ireland, Section 5 of the Misuse of
Drugs Act 1984 forbids any publication that
‘advocates or encourages … the use of any
controlled drug’ or advertises ‘any use of a pipe,
utensil or other thing for use by persons, for or in
connection with the use of a controlled drug’.
Such a legal constraint may inhibit magazines’
coverage of drug issues. 
Currently in Ireland, independent of this EMCDDA
initiative, a Drug Trend Monitoring System, which
will collect primary data as well as analyse
secondary data on a range of drug use indicators in
order to identify nationwide trends in drug use, is
being piloted by the National Advisory Committee
on Drugs. A report on this pilot, and the methods
that have been tested, is due to be submitted to
the Cabinet Committee on Social Inclusion for
consideration later in 2005. (Brigid Pike)
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The National Drugs Strategy 2001–20081 contains
more than 20 Key Performance Indicators (KPIs)
across its four pillars and under the co-ordination
theme. The KPIs are used to monitor the progress
of the Strategy in meeting its objectives. The Mid-
term review of the National Drugs Strategy2 outlines
progress under each KPI and recommends that a
number of KPIs be replaced, amended or
discontinued. These changes are outlined below
under each of the four pillars and under the co-
ordination theme.
Supply reduction
The National Drugs Strategy identified five KPIs to
measure progress under the supply reduction
pillar. The mid-term review recommends that these
be replaced by three new KPIs. The first of these
relates to the volume of drugs seized: 
■ Volume of drugs seized increased by 50 per
cent based on 2000 figures.
There has been an increase in the volume of drugs
seized in most drug categories using seizures in
2000 as a base. The volume of heroin seized by An
Garda Síochána and Customs and Excise, as
reported in the Garda annual reports, remained
relatively stable between 2000 and 2003.
However, the volume of cannabis resin, cocaine,
amphetamine and ecstasy seized increased during
the same period.
Although the volume of drugs seized can be a
useful indicator of law enforcement activities, a
difficulty with using volume as an indicator is that
the quantities of drugs seized can vary significantly
from year to year, with a few very large seizures in
one year distorting the overall picture. The number
of separate seizures is generally regarded as a more
useful indicator. The second KPI recommended
addresses this issue by focusing on the number
rather than the volume of seizures:
■ Number of seizures increased by 20 per cent
based on 2004 figures.
The mid-term review reports a public perception
that drug law enforcement is focused
disproportionately on possession rather than on
supply prosecutions. Consequently, the third new
supply reduction KPI focuses on supply offences:
■ Number of supply detections increased by 20
per cent based on 2004 figures.
Prevention 
The National Drugs Strategy set out nine KPIs to
measure progress under the prevention pillar. The
mid-term review recommends replacing these with
four new KPIs, two relating to demand reduction
and two to addressing educational disadvantage:
■ The 3 Source Capture–Recapture study
estimate of opiate misusers, which will be
released in 2007, to show a stabilisation in
terms of overall numbers and to show a
reduction of 5 per cent in the prevalence rate
based on 2001 figures (published in 2003). 
■ The NACD Drug Prevalence Survey, due to be
released in 2007, to show a reduction of 5
per cent in the prevalence rate of recent and
current use of illicit drugs in the overall
population based on the 2002/03 rate.3
■ Substance use policies in place in 100 per
cent of schools. 
■ Early school leaving in local drugs task force
(LDTF) areas reduced by 10 per cent based
on the 2005/06 rate.
Repeated NACD surveys over time will be very useful
for monitoring the impact of the National Drugs
Awareness Campaign. The Capture–Recapture study
and the NACD Drug Prevalence Survey have
replaced the ESPAD study4 as data sources to assess
progress under the prevention pillar in reducing
demand for drugs among the target populations.
However, these studies have limitations in measuring
a reduction or otherwise in drug use among 15–16-
year-olds in the school-going population. Though
both studies collect data on 15- and 16-year-olds,
the sample sizes for each study would need to be
much larger to provide robust estimates for each
two-year band. Indeed, the research team behind
the NACD prevalence study concedes that estimates
produced for the total population can be treated
more robustly than those for sub-groups of the
population, such as different age groups.5 This is
because the sample size was calculated to provide a
total estimate rather than an estimate for each age
band. The studies would also need to ascertain who
among the respondents aged 15 and 16 years were
attending school. This information was given by the
ESPAD study. Half of the 16 actions under the
prevention pillar target school-going young people
through interventions designed to address
educational disadvantage and prevention of
substance misuse. The ESPAD survey was designed to
obtain data on the school-going population and is
carried out every four years. It is therefore, in this
case, a more appropriate tool for monitoring
progress and making comparisons over time than a
general population survey.
The second two new KPIs are closely linked. Both
assess progress on actions designed to address
educational disadvantage. Consistent monitoring
and implementation of substance-use policies in all
schools can create a climate where students with
substance misuse issues can be supported rather
than disciplined. This concern was raised during
the consultation stage of the mid-term review. An
over-emphasis on disciplinary sanctions through
suspensions and expulsions can contribute to early
Recommended changes to Drugs Strategy
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school leaving. Also, schools now have a legal
obligation to report absences and expulsions to
the National Educational Welfare Board, who have
been instructed to prioritise schools in LDTF areas.
Early identification of substance-related
absenteeism and expulsions in schools in LDTF
areas will lead to early intervention by educational
welfare officers, in conjunction with teachers,
parents and specialised substance misuse
counsellors. This process can support young
people in remaining in mainstream education. 
The mid-term review does not identify the sources
of data for this KPI.
Treatment and rehabilitation 
The National Drugs Strategy identified seven KPIs
to measure progress under the treatment pillar. The
mid-term review recommends that these be
replaced by four new KPIs. The 2001 KPIs monitor
progress in the provision of treatment places,
prison-based treatment services, service-user
charters and rehabilitation. The number of
treatment places for opiate addiction increased
from 6,000 by end 2001 to 7,390 places by end
March 2005; this KPI has been achieved. According
to the mid-term review, a number of services have
drafted service-user charters. Although the review
recognised that more needs to be done, the prison
services have developed an infrastructure for the
delivery of methadone treatment and set up a
number of drug-free units since 2001. The
introduction of counselling services and the
development of post-release arrangements for
those requiring treatment or harm-reduction
services will be required in the future; this KPI has
been discontinued without explanation.
The KPI on treatment has been revised to reflect
the diversity of drug types and the number of
drugs used by those seeking treatment, and
requires that: 
■ 100 per cent of problematic drug users will
access appropriate treatment within one
month after assessment.
A set of guidelines has been developed and agreed
(although not published) to guide the treatment of
problem drug users under 18 years old and the
original KPI has been replaced by a new indicator:
■ 100 per cent of problematic drug users aged
under 18 will access treatment within one
month after assessment.
The two KPIs relating to treatment will be
measured through the Health Service Executive
Addiction Services and the HRB National Drug
Treatment Reporting System. 
Two indicators pertaining to harm reduction have
been introduced:
■ Harm reduction facilities available, including
needle exchange where necessary, open
during the day, and at evenings and
weekends, according to need, in every local
health office area;
■ Incidence of HIV in drug users stabilised
based on 2004 figures.
The second of these is based on an increased
number of HIV cases among drug users in 2004
(see ‘Newly diagnosed HIV infections in Ireland’,
Fig. 1, on p.6 of this issue). 
The review recommends that the KPI pertaining to
‘training and employment for treated drug users’
be moved to the new rehabilitation pillar. A
working group has been set up to define the scope
of rehabilitation and identify the actions to be
implemented under the rehabilitation pillar. 
Research
The National Drugs Strategy identified two KPIs
under the research pillar. The mid-term review
recommends that these be replaced by three new
KPIs. The first, ‘eliminate all major gaps in drugs
research by the end of 2003’, has been reworded
to take account of the number of research actions
completed to date and has had its time period
extended to mid-2008. The second has been split
into two KPIs, which are:
■ Publish an annual report on the nature and
extent of the drug problem in Ireland,
drawing on available data; and
■ Publish a report every two years on progress
being made in achieving the objectives and
aims set out in the Strategy.
Co-ordination
Although not a ‘pillar’, co-ordination is a key
theme of the National Drugs Strategy, with its 
own objective and four KPIs. The objective for co-
ordination is ‘to have in place an efficient and
effective framework for implementing the National
Drugs Strategy’. The associated KPIs have largely
been achieved. 
While not proposing new KPIs for the co-
ordination objective, the mid-term review makes
two recommendations designed to strengthen
high-level co-ordination between the statutory
agencies and the multiple service providers and
community and voluntary groups in the drugs
area. It calls for expanded representation of the
community and voluntary sectors, and the
inclusion of additional government departments
and statutory and other state agencies with
responsibilities in the drugs area, on both the
Inter-Departmental Group on Drugs (IDG) and the
National Drugs Strategy Team (NDST). 
Changes to Drugs Strategy (continued)
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Comments by the Steering Group suggest that co-
ordination at regional and local levels also
continues to be a challenge. For example:
… representatives of the statutory bodies
who are members of LDTFs and RDTFs
need to be mindful of their role. In
particular, they should consult with – and
bring relevant information to – their Task
Forces regarding developments at both
local and national levels within their
organisations that impact on progressing
actions in the NDS. They also need to
ensure that their parent organisations are
aware of developments within the Task
Forces and how these developments
impact on their agencies. (Section 7.8)
However, the perceived difficulties in achieving
effective co-ordination at regional and local level,
arguably more complex and more challenging
than at national level, are not identified in the mid-
term review as a ‘key issue’ and are not the subject
of a formal recommendation, let alone a new KPI. 
Conclusion
The mid-term review recommends significant
changes to the number and content of indicators
used to measure progress under the National Drugs
Strategy. Some of the revised KPIs are in recognition
of achievements in certain areas, a response to
changing circumstances or an acknowledgement of
difficulties with existing indicators. The rationale
behind other changes is less clear. The changes in
indicators to measure supply reduction and
treatment would appear sensible. The linking of
school-based substance policy with early school
leaving recognises the overlap between these two
areas and the wider responsibility of the educational
system in prevention work. 
The use of population studies to monitor progress
of young people still at school under the
prevention pillar is problematic. While recognising
that further improvements are required in prison
treatment services, the KPI relating to prison-based
services has been removed without any
explanation. The absence of any indicators under
the co-ordination theme allows no objective
measure for determining progress in this area. It is
important that these inconsistencies are recognised
if the KPIs are to do what they were designed for,
that is, to provide measurable, verifiable and
relevant indicators of progress for all aspects of the
National Drugs Strategy. (Johnny Connolly, Brian
Galvin, Martin Keane, Jean Long and Brigid Pike)
1. Department of Tourism, Sport and Recreation (2001)
Building on experience: National Drugs Strategy 2001–2008.
Dublin: Stationery Office.
2. Steering Group for the Mid-term Review of the National
Drugs Strategy (2005) Mid-term review of the National
Drugs Strategy 2001–2008. Dublin: Department of
Community, Rural and Gaeltacht Affairs.
3. National Advisory Committee on Drugs (NACD) and Drug
and Alcohol Information and Research Unit (DAIRU) (2005)
Drug use in Ireland and Northern Ireland – first results
(revised) from the 2002/2003 Drug Prevalence Survey.
Dublin: NACD. (First published October 2003, revised June
2005) www.nacd.ie/publications/prevalence_survey.html 
4. Hibell et al. (2004) The ESPAD Report 2003: Alcohol and
other drug use among students in 35 European countries.
Stockholm: The Swedish Council for Information on
Alcohol and Other Drugs (CAN), Council of Europe, Co-
operation Group to Combat Drug Abuse and Illicit
Trafficking in Drugs (Pompidou Group).
5. National Advisory Committee on Drugs (NACD) and Drug
and Alcohol Information and Research Unit (DAIRU) (2003)
Drug use in Ireland and Northern Ireland. First results from the
2002/2003 Drug Prevalence Survey – a summary of the
methodology. Dublin: NACD. 
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‘We’re people too’ – Drug users’ views
on the health services
A collaborative piece of action research involving
the Participation and Practice of Rights Project
(PPR), the Union for Improved Services,
Communication and Education (UISCE) and the
Mountjoy Street Family Practice has sought to
identify and address issues confronted by drug
users in relation to Irish health services.
The PPR is an initiative linking representatives of
community networks from North Dublin and
North Belfast which advocates the adoption of a
rights-based approach in addressing social and
economic issues confronting communities. UISCE is
a group made up of drug users, ex-users and
professionals who seek to ensure that the views of
the drug user inform the development of drug
policy and treatment responses. Mountjoy Street
Practice is a GP-run family practice which has a
large group of patients receiving methadone
maintenance. It also provided financial and
technical support to the research project, as did
the Royal College of Surgeons in Ireland.
The initial stage of the research involved focus
group discussions with 25 drug users about their
experiences of health care. Topics of discussion
included drug users’ perceptions as to how they
were treated with regard to their health
entitlements. Drug users’ views of health services
were then ascertained so as to facilitate practical
improvements in services. Participants were
identified by UISCE through being approached
outside the City Clinic drug treatment centre,
through informal meetings on the street and
6drugnet
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through visits to flat complexes. Three focus
groups were held on three consecutive days,
involving a total of six hours of recorded
discussion. Four months later, after the interviews
were analysed using a thematic approach,
participants were brought back together to verify
the initial findings and to prioritise problems with
services. Thirteen of the original 25 participants
took part in this feedback session.
Concerns raised included perceptions of poor
attitudes towards drug users among some staff at
some acute hospitals and perceptions of
discriminatory treatment of users at some hospitals
and pharmacies. Some users regarded the use of
identifying stickers on their charts and the use of
signage, such as ‘infectious diseases’, as insensitive
and stigmatising. Some participants felt that GPs
were reluctant to take drug users onto their lists
and that, since GPs are gate keepers to medical
cards, this created obstacles to health care. Dental
care was identified as an important issue. However,
some users reported difficulties in obtaining access
to dentists. A number of concerns were raised in
relation to treatment services, particularly in
relation to privacy and confidentiality issues and a
consequent reluctance to enter counselling.
Related to this broader treatment need, another
theme which emerged was the perceived need to
develop a more holistic, individual-centred
approach to address the multi-faceted problems
being encountered by users. A broad consensus
that methadone was not the whole answer to
these complex issues came out of the focus
groups. The focus groups also heard many positive
comments about individual staff members and
institutions.
One of the most innovative aspects of the research
project was the presentation of the research
findings to an informal meeting of service
providers and key stakeholders. This meeting,
which was attended by representatives from
Merchants Quay, the Health Service Executive, St
James’s Hospital, the Drug Misuse Research
Division of the Health Research Board, AOM
Addiction Services, the North Inner City
Partnership, UISCE, PPR, a pharmacist, GPs and a
dentist with experience in treating drug users,
provided a useful opportunity to discuss the
findings of the report and identify practical steps
to address the issues identified. The report is due
to be published shortly. (Johnny Connolly)
‘We’re people too’ (continued)
Some
participants felt
that GPs were
reluctant to take
drug users onto
their lists.
Newly diagnosed HIV infections in Ireland
By the end of 2004 there were 3,764 diagnosed
HIV cases in Ireland, of which 1,203 (32%) were
probably infected through injecting drug use.1 In
2004, there were 365 newly diagnosed cases
reported to the Health Protection Surveillance
Centre, of which 71 (20%) were infected through
injecting drug use (Figure 1). This represents an
increase on the numbers of new HIV cases in 2002
(50) and 2003 (49). Of the 71 new HIV cases, 44
were male and 27 were female and the average
age was 30.1 years. Of the 64 cases for whom
place of residence was known, 60 lived in the HSE
Eastern Region. The authors of the report
highlighted the need to continue to promote the
use of harm-reduction measures among injecting
drug users. (Jean Long)
1. Health Protection Surveillance Centre (2005) Newly
diagnosed HIV infections in Ireland: Quarters 3 & 4 2004 and
2004 annual summary. Dublin: Health Service Executive.
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Figure 1   Number of new cases of HIV among injecting drug users by year of diagnosis reported in Ireland,
1986 to 2002 (adapted from Kelly and Clarke 2000; National Disease Surveillance Centre 2002, 2003, 2004;
Health Protection Surveillance Centre 2005)
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The National Drugs Awareness campaign was
launched in May 2003 under the prevention,
education and awareness pillar of the National
Drugs Strategy 2001–2008. The three-year
campaign aims to provide information about the
dangers of drug misuse to the general population.
The first and second phases of the campaign were
targeted at the general population and parents
respectively. The objectives were to provide
information which enable people to make the right
choices and to encourage more open
communication between parents and children.
The third phase of the National Drugs Awareness
Campaign, launched in October 2004, focuses on
cocaine. The latest element of the campaign,
launched in July 2005, concentrates on the dangers
of mixing cocaine with other drugs, especially
alcohol. According to the information provided on
the www.drugsinfo.ie website, ‘cocaine when taken
with alcohol combines in the system to form another
drug, Cocaethylene, which is more toxic than either
drug alone. Cocaethylene can seriously affect the
normal functioning of the heart and has been a
contributory factor in many cocaine related deaths’.
This phase of the campaign includes placing posters
in the restrooms of 70 large entertainment venues
throughout Ireland in conjunction with messages on
beer mats in pubs and clubs and print advertisements
in the national press. The posters use the imagery of
nursery rhyme characters to illustrate the dangers
associated with mixing cocaine and alcohol. 
It remains to be seen to what extent providing
information and heightening awareness can bring
about a change in individual and group behaviour.
Nonetheless, people have a right to accurate
information on the risks associated with particular
forms of behaviour, such as consuming alcohol in
combination with cocaine use. This latest phase of
the campaign, targeting recreational cocaine users in
the club and pub scene, is an important step in
providing accurate information in a relevant setting. 
Following an open tendering competition, the
National Advisory Committee on Drugs
commissioned Dr Saoirse Nic Gabhainn and Dr Jane
Sixsmith of the Centre for Health Promotion Studies,
National University of Ireland, Galway, to track the
development and delivery of the campaign. A final
report is due at the beginning of 2006. (Martin Keane)
National Drugs Awareness Campaign 
In March 2005, the Joint Oireachtas Committee on
Justice, Equality, Defence and Women’s Rights
conducted a review of community policing in
Ireland in light of proposals contained in Chapter 4
of the Garda Síochána Bill 2004 to establish new
local policing structures.1 Many of the
recommendations of the Joint Committee have
been incorporated into the Bill, which is now in its
final stages in the Oireachtas.2
An important amendment to the Bill has been the
inclusion of the Minister for Community, Rural and
Gaeltacht Affairs, who has responsibility for the
National Drugs Strategy, in the preparation of
guidelines concerning the establishment and
maintenance of joint policing committees (JPCs) by
local authorities and the Garda Commissioner. The
steering group which oversaw the mid-term review
of the National Drugs Strategy highlighted
concerns raised during its consultation process
about the pace at which community policing fora
were developing in drugs task force areas. In light
of these concerns, and developments with regard
to the Garda Bill, a new action has been
incorporated into the Strategy: ‘Taking into account
the provisions of the Garda Síochána Bill 2004,
Community Policing Fora should be extended to all
Local Drugs Task Force areas and to other areas
experiencing problems of drug misuse’.3
Another important issue raised during the Joint
Oireachtas Committee related to the perceived
importance of including representatives of the
community and voluntary sector on the JPCs. The
Bill now provides for the inclusion on the JPCs of
‘persons representing local community interests’.4
Another important tier in the proposed new local
policing structures is the establishment of local
policing fora. However, concerns were expressed
Amendments to Garda Bill 2004 enhance
community policing
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during the Joint Committee review in relation to a
provision in the Bill which necessitated the Garda
Commissioner’s consent for the establishment of
such fora. The Bill has now been amended to
provide for the establishment of such fora by JPCs
in consultation with the local Garda superintendent
‘as the committee considers necessary’.5
The Bill further states that in the event of a dispute
arising over the establishment of local policing fora
the JPC must submit the dispute to the Minister for
Justice, who, following consultation with the
Minister for the Environment and the Minister for
Community, Rural and Gaeltacht Affairs, shall
decide on the matter.6
Joe Costello TD, rapporteur to the Joint Oireachtas
Committee, welcomed the amendments to the
Bill, in particular the opening up of membership of
joint policing committees to the community.
Speaking to Drugnet Ireland, deputy Costello said:
‘The inclusion of the community as an integral part
of the partnership will be crucial to the success of
the new direction in policing envisaged in the
legislation.’ (Johnny Connolly)
1. See Drugnet Ireland, Issue 14, Summer 2005, p.12, for a
report of this review.
2. The report and recommendations of the Joint Committee
are on the Oireachtas website at www.oireachtas.ie 
3. Steering Group for the Mid-term Review of the National
Drugs Strategy (2005) Mid-term review of the National
Drugs Strategy 2001–2008. Dublin: Stationery Office, p. 21.
4. Garda Síochána Bill 2004, s35(2)(b)(v)
5. Garda Síochána Bill 2004, s36(2)(d)
6. Garda Síochána Bill 2004, s36(3)
Welcome to the twelfth EDDRA (Exchange on Drug
Demand Reduction Action) column. In this issue
the column will focus on the inclusion of the
EDDRA database in the EU Drugs Action Plan
(2005–2008) as a key resource in storing and
disseminating information on evaluated best
practice in reducing demand for drugs. 
In December 2004, the European Council endorsed
the EU Drugs Strategy (2005–2012), which sets the
framework, objectives and priorities for two
consecutive four-year Action Plans to be brought
forward by the European Commission. The latest EU
Drugs Action Plan (2005–2008) is the first of the
proposed four-year action plans. A key objective
under the demand reduction pillar of this Action Plan
is to improve coverage and effectiveness of, and
access to, drug demand reduction measures. Under
this objective, member states and the EMCDDA are
given responsibility for the following actions: 
■ To improve coverage, accessibility, quality
and evaluation of drug demand reduction
programmes and ensure effective
dissemination of evaluated best practices
■ To ensure more effective use and regular
updating of the EMCDDA-based EDDRA and
other databases
In June 2005 the EDDRA database contained a total
of 520 entries, including 50 from Ireland. All
EDDRA entries have been assessed as examples of
best practice. This means they have satisfied the
quality auditing process by demonstrating internal
consistency with stated rationale for existence,
meaningful aims and objectives, a sound theoretical
base and an evaluation component. The latter
means that either the project or programme is
designed to withstand an evaluation or it has been
evaluated. This ensures that data on the EDDRA
database is of sufficient quality to inform on what
constitutes an example of best practice. 
Policy makers and practitioners in Ireland can learn
important lessons from the work of our EU
counterparts regarding what works well and not so
well in reducing demand for drugs. Similarly, we in
Ireland can share with our EU counterparts our
experiences of what is effective by disseminating our
examples of best practice. The EDDRA database is
an ideal instrument to facilitate this process of
sharing and learning and is rightly regarded as such
in the current EU Drugs Action Plan.
The quality of information included on the EDDRA
database depends on regular updating and the
continued promotion of an evaluation culture in
the field of drug demand reduction action in all
member states. In Ireland, this requires that those
involved in projects and programmes currently
included on EDDRA provide updated information
on their work when applicable. New entries with
an evaluation component as outlined above are
also welcome and will be quality assessed using
EMCDDA criteria. (Martin Keane) 
If you wish to provide updated information
or submit a new entry, contact the EDDRA
Manager for Ireland, Mr Martin Keane, at
the Drug Misuse Research Division, Health
Research Board, Holbrook House, Holles
Street, Dublin 2. Tel: 01 6761176 ext 169
or Email: mkeane@hrb.ie
More information on the EDDRA database
can be obtained from the EMCDDA
website at www.emcdda.eu.int 
Amendments to Garda Bill 2004 (continued)
The EDDRA column
Latest EU Drugs Action Plan
The aim of this column is
to inform people about
the EDDRA online
database, which exists to
provide information on
examples of best practice
interventions to policy
makers and those
working in the drugs
area across Europe, and
to promote the role of
evaluation in reducing
demand for drugs. The
database is co-ordinated
by the European
Monitoring Centre for
Drugs and Drug
Addiction (EMCDDA).
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The Next Step Initiative
A model of intervention to support
women involved in prostitution 
The Next Step Initiative (NSI) report1 was
published by the voluntary organisation, Ruhama,
on 7 June 2005. The report covers a participatory
action research project undertaken by Ruhama
and funded through the Equality for Women
Measure under the National Development Plan.
The aim of the NSI project was to develop a
model of intervention to support women involved
in prostitution to access the social economy,
community education or local employment. The
core objectives of the initiative were:
■ to undertake participatory research with a
cohort of women who have experienced
prostitution in order to identify the range of
barriers, internal and external, that affect
them
■ to use this learning to develop a model of
intervention that could facilitate marginalised
women in taking the ‘next step’ in their
personal development.
Third Systems Approaches (TSA) conducted the
research in Dublin over a 14-month period
between 2003 and 2004. The women were
recruited through the Ruhama organisation and
were assured of back-up support in the event of
sensitive issues arising for them. The research
engaged with a total of 19 women in the course
of 350 hours of fieldwork. The majority were
interviewed five times for an hour each time, with
some women engaging in nine interviews and two
engaging in single one-hour interviews. The
spacing of interviews allowed time for the women
to revise and reflect on what they had previously
discussed. The interviews consisted of open-ended
questions around five key areas:
■ childhood experiences
■ financial situation
■ circumstances of prostitution
■ survival strategies
■ relational issues with family, clients and
support networks.
The interviews were not recorded but researchers
made notes which were written up when the
interview terminated. The interviewees were then
asked to review the notes and approve and make
changes or additions.
Most of the women interviewed had engaged with
the support services of Ruhama for a number of
years and were keen to explore ways of taking
further steps away from their experiences of
prostitution. For some, this experience included
additional problems of alcohol and drug use. For
example, when actively engaged in prostitution,
some of the women reported being 'out every
night' to support a drug habit and a pimp. The
women were also aware of the dangers of not
being fully alert due to the effects of alcohol and
drugs and the inherent risks involved in prostitution.
The research identified drug and alcohol use as
primarily a survival mechanism for some of the
women. For example, they would habitually get
drunk or stoned or use prescription drugs in order
to work and then use drugs and alcohol ‘to numb
the pain’ of prostitution.
The authors report that, for women working in
prostitution, the ability to maintain strict boundaries
between their private and public selves is an
extremely important psychological tool for survival.
However, for some of the women in this research,
the use of drugs acted against this separation and
'mixed it all up'. In addition, when some of the
women tried to access drug-treatment services, their
experience was that the policies in place in such
services were a major barrier to their moving on. 
The NSI project developed a model of support and
intervention through interviews with women with
experience of prostitution, women with
experience of addiction and with staff from a
homeless support organisation. The model is
designed to respond to the following:
■ The factors affecting women's entry into and
experience of prostitution, which are largely
outside the control of the women and often
include structural barriers to taking the next
step, such as reduced access to employment
and training;
■ The individual challenges for women as they
take the next step and overcome the impact
of prostitution; services need to be long-
term, one-to-one and flexible;
■ The need for specialist knowledge on the
part of service providers to deliver supports
as well as understand the realities of
prostitution for women.
The authors note the lack of research into the
experiences of women engaged in prostitution in
an Irish context; this report deserves to be
welcomed as an attempt to narrow this gap.
However, the real strength of this research is the
development of the support model, which has
come to fruition through the participation of the
women in the research process. During its
development, the model was tested for credibility
and legitimacy among a number of marginalised
women, service providers and specialist services,
and the feedback suggests widespread
endorsement. 
The research
identified drug
and alcohol use
as primarily a
survival
mechanism for
some of the
women.
The authors note
the lack of
research into the
experiences of
women engaged
in prostitution in
an Irish context.
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The authors make a number of recommendations
to policy makers, service providers and specialist
services on the premise that the model of support
and intervention proposed is accepted and
endorsed as the optimum means of supporting
women involved in prostitution to take the next
step in their personal development journey. In
essence, the recommendations represent the
aspirations of marginalised women who seek to
partake in the activities of mainstream society. It is
incumbent on generic service providers and
specialist services that engage with women in
prostitution to facilitate these aspirations by
implementing the model proposed. (Martin Keane)
1. TSA Consultancy (2005) The Next Step Initiative: Research
report on barriers affecting women in prostitution. Dublin:
Ruhama.
A copy of the report can be obtained from
Ruhama, Senior House, All Hallows College,
Drumcondra, Dublin 9. Tel: 01 836 0292; Fax: 01
836 0268; Email: admin@ruhama.ie ;
www.ruhama.ie
The Next Step Initiative (continued)
Overview 1: Drug-related deaths in
Ireland, 1990 to 2002 
This publication is the first in a series from the
Drug Misuse Research Division of the Health
Research Board. Each issue of this new series will
provide a comprehensive, objective and reliable
review of specific drug-related issues in Ireland.
The data presented in this publication describe
what is known about drug-related deaths and
deaths among drug users in Ireland between 1990
and 2002. The analysis presented is based on data
reported to the General Mortality Register, and on
ad hoc studies that extracted data from the
coroners’ records, the Central Treatment List, and
the HIV/AIDS surveillance system, and on an
epidemic investigation.1
The main findings are: 
■ Between 1990 and 1994, there was a small
but steady increase in the number of drug-
related deaths, from 7 to 19, reported by the
General Mortality Register in Ireland (Figure
1). Between 1995 and 2000, there was a
substantial increase, from 43 to 119, and in
2001 there was a considerable decline (to 88)
in the number of drug-related deaths. In
2002, the number of drug-related deaths
increased marginally (to 91) when compared
to 2001. 
■ According to data from the General Mortality
Register, almost all drug-related deaths
between 1991 and 1994 occurred in Dublin
(Figure 2). Between 1995 and 2000, there
was a substantial increase in drug-related
deaths in Dublin, from 39 to 90, and a steady
increase outside the Dublin area, from 4 to
29. In 2001, there was a sharp decrease in the
number of drug-related deaths in Dublin (to
55) and a continued increase outside Dublin
(to 33 in 2001 and 35 in 2002). These data
follow trends in treated problem opiate use. 
■ From 1998 to 2001, the annual numbers of
opiate-related deaths extracted by Byrne2 from
the Dublin coroners’ records were consistently
higher than those reported by the General
Mortality Register. These variations may be
related to differences in the definition of
opiate-related deaths applied in each case.
The General Mortality Register considers
opiate-related deaths to be those occurring as
a direct result of opiate use, while Byrne
investigated all the coroners’ cases that tested
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Figure 1   Number of direct drug-related deaths 
in Ireland, by national and by European definition,
reported by the CSO, 1990 to 2002 (unpublished
data from the vital statistics)
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positive for opiate use and so included a
broader range of opiate-related deaths. 
■ Opiate-related deaths account for the largest
proportion of deaths among drug users in
Ireland. The review of coroners’ cases found
that polysubstance use was common among
drug users who had died. 
■ According to both the General Mortality
Register and Byrne’s review of coroners’
data,2, 3 those who died as a result of drug 
use were older than their counterparts in
treatment, indicating an increased risk 
with age. As expected, more men than
women died.
■ Following a review of the Dublin coroners’
cases, Byrne reported that 13 per cent of
drug-related deaths were associated with
imprisonment or recent release from prison. 
■ Injecting drug use is associated with infection
and subsequent mortality. 
■ Deaths as an indirect result of drug use are
not systematically documented and have
been assessed only in small-scale studies in
Dublin. The findings of these studies indicate
an underestimate in opiate-related deaths but
provide little information on other drug-
related deaths. A system is required to
document drug-related deaths and deaths
among drug users. (Jean Long and Ena Lynn)
1. Long J, Lynn E and Keating J (2005) Drug-related deaths in
Ireland, 1990–2002. Overview 1. Dublin: Health Research
Board. 
2. Byrne R (2001) Opiate-related deaths investigated by the
Dublin City and County Coroners 1998 to 2000. Dublin:
University of Dublin, Addiction Research Centre. 
3. Byrne R (2002) Opiate-related deaths investigated by the
Dublin City and County Coroners 1998 to 2001, Briefing No
2. Dublin: University of Dublin, Addiction Research Centre. 
Drug-related deaths (continued)
Two national registers record drug treatment in
Ireland: the first system is an epidemiological
database that records demand for treatment for
problem alcohol and drug use (known as the
National Drug Treatment Reporting System) and
the second is an administrative database to
regulate the dispensing of methadone treatment
(known as the Central Treatment List). 
National Drug Treatment Reporting System
The National Drug Treatment Reporting System
(NDTRS) is an epidemiological database on treated
problem drug use in Ireland. It was established in
1990 in the Greater Dublin Area and was extended
in 1995 to cover other areas of the country. The
reporting system was originally developed in line
with the Pompidou Group’s Definitive Protocol and
subsequently refined in accordance with the
Treatment Demand Indicator Protocol. The NDTRS
is co-ordinated by staff at the Drug Misuse
Research Division (DMRD) of the Health Research
Board (HRB) on behalf of the Department of
Health and Children. Between 1991 and 2003
compliance with the NDTRS required that one
form be completed for each person who received
treatment for problem drug use at each treatment
centre in a calendar year. Since 2004, compliance
with the NDTRS requires that the total number of
cases in treatment with each treatment provider
on 1 January each year is returned to the DMRD
and that one form is completed for every case who
commences or returns to treatment for problem
alcohol or drug use at each treatment centre. Data
forms are submitted quarterly. Service providers at
drug treatment centres throughout Ireland collect
and submit this data. They collect administrative
details, demographic characteristics, parameters to
measure access to treatment, treatment status
(new versus previously treated cases), problem
substance use in the month preceding this
treatment contact, risk behaviours (associated with
injecting drug use) and initial treatment type. 
At national level, staff at the DMRD of the HRB
compile anonymous, aggregated data. For the
purpose of the NDTRS, treatment is broadly
defined as ‘any activity which aims to ameliorate
the psychological, medical or social state of
individuals who seek help for their drug problems’.
Treatment options include one or more of the
following: brief interventions, addiction
counselling, medication-free therapy, alternative
therapy, psychiatric treatment, medication
(detoxification for problem alcohol, opiate or
benzodiazepine use, methadone substitution), and
social and occupational reintegration. Clients who
attend needle-exchange services are not included
in this reporting system. Treatment is provided
through residential and non-residential services.
Drug treatment data are viewed as an indirect
indicator of drug misuse as well as a direct
indicator of demand for treatment services. These
data are used at national and European levels to
provide information on the characteristics of clients
entering treatment, and on patterns of drug
misuse, such as types of drugs used and
consumption behaviours. In addition, the data are
used to calculate the performance indicators for
the addiction services. 
Central Treatment List
The Central Treatment List (CTL) was established
under Statutory Instrument No. 225 (Minister for
Health and Children 1998) following the Report of
the Methadone Treatment Services Review Group
(1998). This list is administered by the Drug
Treatment Centre Board on behalf of the Health
Service Executive and is a complete register of all
patients receiving methadone (as treatment for
problem opiate use) in Ireland. When a person is
Byrne reported
that 13 per cent
of drug-related
deaths were
associated with
imprisonment or
recent release
from prison.
NDTRS data are
used at national
and European
levels to provide
information 
on the
characteristics of
clients entering
treatment.
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considered suitable for methadone detoxification or
maintenance, the prescribing doctor applies to the
CTL for a place on the list and a unique number is
allocated to the client. Therefore, each client can
receive their methadone from one source only.
Each client’s name, address, date of birth, gender,
date commenced on methadone, type of
methadone treatment, prescribing doctor and
dispensing pharmacist are recorded on the List. The
CTL is considered complete with respect to the
number of clients who start or recommence
methadone treatment because general practitioners
have a statutory obligation to report the initiation
of treatment and, also, they are paid per client in
treatment. Once on the List, the current treatment
status of the majority of clients can be tracked by
means of transfer and exit records.
Figure 1 presents a comparison of the numbers of
cases reported to the NDTRS and to the CTL. As
expected, the numbers of cases reported to the
NDTRS are higher than those reported to the CTL.
Between 1991 and 2003 compliance with the
NDTRS required that one form be completed for
each person who received treatment for problem
drug use at each treatment centre in a calendar
year, whereas compliance with the CTL requires
forms only for those receiving methadone. The
difference is not as high as expected because the
data in Figure 1 presents all cases reported to each
system and it is acknowledged that between 1998
and 2003 there was a large increase in the number
of general practitioners providing methadone
treatment services in Ireland. The number of
general practitioners participating in the CTL is
high because it is a statutory requirement and
payments are calculated per client treated, but the
number of general practitioners participating in
the NDTRS is still very low. This deficiency in the
NDTRS will be rectified at the end of 2005 when
all outstanding data for general practitioners’
clients for the period 2001 to 2005 will be
returned and included in future publications. It is
important to note that the number of cases
reported to the CTL presented in Figure 1
represents the total number of individuals treated
with methadone in the calendar year, rather than
the number in treatment at a single point in time. 
Figure 2 presents a comparison of the numbers of
new cases reported to the NDTRS and to the CTL. 
It is clear that more new (incidence) cases are
reported to the NDTRS than to the CTL. The trend
in new cases reported to the CTL is falling, while
the trend in new cases reported to the NDTRS is
rising. The fall in the number of new cases
reported to the CTL is influenced by the decrease
in opiate use in both the HSE Northern and the
HSE South Western Areas (of Dublin), while the
increase in new cases reported to the NDTRS is
accounted for by an increase in problem cannabis
use and, to a much lesser extent, problem cocaine
use in Ireland. (Jean Long)
Recording drug treatment in Ireland (continued)
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Publication of occasional papers on
treated drug use in the HSE Eastern
Region and nationally, 1998 to 2002
Three occasional papers were published by the
Drug Misuse Research Division in this quarter. 
Occasional Paper No. 151 provides a description of
demand for drug treatment services in the HSE
Eastern Region (Dublin, Kildare and Wicklow)
provided by the Drug Treatment Centre Board, the
HSE East Coast Area (of Dublin and Wicklow), the
HSE South Western Area (of Dublin and Wicklow
and all of Kildare) and the HSE Northern (Dublin)
Area. The total number of cases treated increased
by almost 20 per cent in the HSE Eastern Region
between 1998 and 2002, with the largest increase
occurring in the HSE Northern (Dublin) Area,
where numbers rose by 62 per cent, from 1,154 in
1998 to 1,871 in 2002. In the HSE South Western
Area, the increase was also considerable, at 50 per
cent, from 1,621 in 1998 to 2,407 in 2002. The
total number of cases treated by the Drug
Treatment Centre Board decreased by more than
one quarter in the five-year period. The Drug
Treatment Centre Board is a tertiary service which
provides advice to referring practitioners on the
management of clients with complex problems
and provides treatment for clients with more
serious drug problems or co-morbid psychiatric
illness. Therefore, a number of clients attending
this Centre are assessed only and then referred
back to their practitioner (with advice on future
management) or referred to another more
appropriate treatment provider. In the three HSE
areas in the HSE Eastern Region, the number of
drug treatment services increased, as did the
demand for such services. 
Occasional Paper No. 162 provides a description of
trends in treated problem drug use among cases
living in the HSE Eastern Region. Of the 27,674
cases treated for problem drug use and living in
the HSE Eastern Region between 1998 and 2002,
4,871 (18%) were treated for the first time.
Overall, the total number of cases increased by 23
per cent over the five-year period. There was an
increase in the number and proportion of
previously treated cases, from 3,815 (75%) in
1998 to 5,324 (85%) in 2002. There was a steady
decrease in the number and proportion of new
cases, from 1,140 (22%) in 1998 to 790 (13%) in
2002. The increase in the total numbers can be
attributed to the fact that the numbers continuing
in and returning to treatment were increasing by a
larger rate than the number of new cases entering
treatment in each year. This suggests that the
increased service provision was to a large extent
able to cope with demand for drug treatment
services from persons living in the HSE Eastern
Region. Between 1998 and 2002, opiates were the
most common main problem drug reported by
both new and previously treated cases in the
region. The total number of cases living in the
region who reported opiates as their main problem
drug increased by 27 per cent, from 4,652 in 1998
to 5,921 in 2002, and opiates dominated the main
problem drug profile among treated cases living in
this area. The number of new cases treated who
reported problem opiate use decreased by 29 per
cent, from 912 in 1998 to 648 in 2002. The
incidence of treated problem drug use among
persons aged between 15 and 64 years living in
the HSE East Coast Area (of Dublin and Wicklow)
increased by 73 per cent, from 30 per 100,000 in
1998 to 52 per 100,000 in 2002 (Figure 1). The
incidence in the HSE South Western Area (of
Dublin and Wicklow and all of Kildare) halved,
from 129 per 100,000 in 1998 to 63 per 100,000
in 2002 and the incidence in the HSE Northern
(Dublin) Area almost halved also, from 136 per
100,000 in 1998 to 71 per 100,000 in 2002. 
Occasional Paper No. 173 provides a description of
trends in treated problem drug use among cases
living in Ireland. The total numbers include 33,391
cases who lived and were treated in Ireland
between 1998 and 2002. During the reporting
period, opiates were the most frequently reported
main problem drug, while cannabis was the
second most frequently reported main problem
drug by treated cases in Ireland. The number of
new cases treated who reported problem opiate
use decreased by 21 per cent, from a peak of 922
in 1999 to 729 in 2002. The number of new cases
treated who reported problem cannabis use
increased by 144 per cent, from 379 in 1998 to
925 in 2002. The number of new cases treated
who reported cocaine as their main problem drug,
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Figure 1   Incidence of treated problem drug use
among persons aged between 15 and 64 years
living in the HSE Eastern Region, per 100,000
population (Central Statistics Office 2003), based 
on returns to the NDTRS, 1998 to 2002 
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though small, increased consistently between 1999
and 2002. The incidence rates of treated problem
drug use among persons aged between 15 and 64
years living in Ireland, expressed per 100,000 of
the population, were examined by county for the
period 1998 to 2002 (Figure 2). The incidence
rates were highest in Carlow, Dublin and Waterford
(with over 100 cases per 100,000 of the
population aged 15 to 64 years), followed by Cork,
Louth, Meath, Westmeath, Sligo, Tipperary and
Limerick (with between 50 and 99 cases per
100,000). Excluding Sligo, the incidence rates
were lowest in western counties (with between 10
and 19 cases per 100,000). (Jean Long)
1. Kelly F, Lynn E and Long J (2005) Treatment demand in the
Health Service Executive Eastern Region, 1998 to 2002.
Occasional Paper No. 15. Dublin: Health Research Board.
2. Kelly F, Long J and Lynn E (2005) Trends in treated problem
drug use in the Health Service Executive Eastern Region, 1998
to 2002. Occasional Paper No. 16. Dublin: Health Research
Board.
3. Long J, Lynn E and Kelly F (2005) Trends in treated problem
drug use in Ireland, 1998 to 2002. Occasional Paper No. 17.
Dublin: Health Research Board.
Papers on treated drug use (continued)
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Figure 2   Average annual incidence of treated problem drug use among persons aged 15 to 64 years living in
Ireland, by HSE area, based on returns to the NDTRS per 100,000 of the population, 1998 to 2003 (Central
Statistics Office 2003)
In mid July, Fionnola Kelly left the Drug
Misuse Research Division where she had
worked as an analyst on the National Drug
Treatment Reporting System since January
2003. She is working as a data manager at
the Economic and Social Research Institute.
Fionnola made a significant contribution to
the NDTRS where she participated in the
collection of the backlog of data for 2001 and
2002, a substantial revision of the NDTRS
protocol and the development of a
computerised data-entry programme.
Fionnola managed data collection for the HSE
areas outside the Eastern Region and will be
missed by her data co-ordination colleagues
in these areas. Fionnola co-authored a
number of occasional papers and was the
lead author for Occasional Papers 15 and 16.
Her colleagues at the DMRD will miss
Fionnola’s friendly, helpful and thoughtful
approach to her work on 
the NDTRS. 
Trends in treated problem drug  
use in Ireland, 1998 to 2002
Occasional Paper No. 17 / 2005
Improving health through research and information
Summary
The data presented in this paper describe trends in treated problem drug use in Ireland.
The total numbers include 33,391 cases who lived and were treated in Ireland between
1998 and 2002. In this paper, treated problem drug use is described in relation to
person, place and time. This paper will assist policy makers, service planners and public
health practitioners to develop appropriate responses to problem drug use in the future. 
The analysis presented in this paper is based on data reported to the National Drug
Treatment Reporting System.
The main findings and their implications are: 
• The prevalence of treated problem drug use among persons aged between 15 and
64 years living in Ireland, expressed per 100,000 of the population, increased by 27
per cent, from 225.4 in 1998 to 286.9 in 2002. The increased prevalence of treated
problem drug use indicates that problem drug use is a chronic health condition that
requires repeated treatment over time. 
• The incidence of treated problem drug use among persons aged between 15 and 64
years living in Ireland, expressed per 100,000 of the population, increased by 24 per
cent, from 59.0 in 1998 to 73.3 in 2001, and subsequently decreased by 6 per cent
in 2002. The decreased incidence observed in 2002 masks two separate trends. The
first trend observed is that the incidence of treated problem drug use in the areas
outside the Health Service Executive Eastern Region (Dublin, Kildare and Wicklow)
almost trebled, from 24.8 per 100,000 of the population in 1998 to 69.7 per
100,000 in 2002 (Long et al. 2004). The second trend is a decrease in the incidence
of treated problem drug use (specifically opiates) in Dublin between 2000 and 2002
(Kelly et al. 2005). The decrease in the incidence of treated problem opiate use may
reflect a decrease in new opiate users in Dublin, saturation of the more vulnerable
populations in Dublin, a switch to other drugs (such as cocaine), a combination of
these factors, or another factor not yet identified. The most likely explanation is a
decrease in new opiate users in certain areas of Dublin and, to a lesser extent, a
switch to other drugs by young people in Dublin.
• The incidence rates of treated problem drug use among persons aged between 
15 and 64 years living in Ireland, expressed per 100,000 of the population, was
examined by county for the period 1998 to 2002. The incidence rates were highest
in Carlow, Dublin and Waterford (with over 100 cases per 100,000 of the 15 to 64
year old population), followed by Cork, Louth, Meath, Westmeath, Sligo, Tipperary
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The Minister for Justice, Equality and Law Reform,
Mr Michael McDowell TD, announced the
publication of new draft prison rules in June. The
rules deal with all aspects of prison life, including
accommodation, visiting rights, discipline, health
and education. The existing prison rules date back
to 1947.
The new rules make provision for the introduction
of compulsory or mandatory drug testing (MDT)
of prisoners, a commitment in the 2001 Agreed
Programme for Government between Fianna Fáil
and the Progressive Democrats.
Section 28 (5) (a) of Prison Rules 2005 states: ‘In
the interest of good order, safety, health and
security and in accordance with directions set
down by the minister, a prisoner … shall, for the
purpose of detecting the presence or use of an
intoxicating liquor or any controlled drug …
provide all or any of the following samples, namely
– urine, saliva, oral buccal transudate, hair.’ The
announcement comes at a time of increased
debate as to the merits of MDT. The Irish Penal
Reform Trust (IPRT) has consistently opposed the
introduction of MDT. Speaking to Drugnet Ireland,
Rick Lines, executive director of the IPRT, said:
‘such testing increases heroin use among prisoners,
increases injecting and the risk of HIV and hepatitis
C transmission through shared syringes, reduces
the uptake of voluntary drug treatment by
prisoners, and wastes money that could be better
spent on more effective drug programmes’. 
In Scotland, recent media speculation suggests
that Scottish prison chiefs are to scrap compulsory
drug testing owing to concerns that it may be
encouraging increased heroin use.1 Fears have
arisen that, as heroin stays in the urine for only
three days – a shorter time period than for drugs
such as cannabis, which may be detected for ten
days or more – inmates are increasingly using
heroin to avoid detection. Under current rules in
Scotland, at least 10 per cent of prisoners are
tested every month.
A programme of MDT based on urine analysis was
implemented in all prisons in England and Wales in
March 1996. The aims of the programme are to
monitor drug taking in custody, to deter prisoners
from misusing drugs and to identify individuals in
need of treatment. Tests undertaken include the
random testing of a proportion of prisoners in
each prison each month. A recent Home Office
study considered the impact and effectiveness of
the programme.2 The Prison Service commissioned
the research to determine how effectively the
programme was achieving its aims and specifically
to determine whether MDT was encouraging
prisoners to use more harmful drugs such as heroin
to avoid detection.
Over 2,000 prisoners were interviewed for the
Home Office study between 2001 and 2002.
Prison staff were also asked their views about the
programme and MDT data were analysed.
Findings were compared with an earlier prison
survey. Among the main findings are:
■ Drug use as measured by monthly random
tests in prisons was found to correlate with
prisoners’ self-reported drug use.
■ Since mandatory drug testing was
introduced, the use of cannabis in prison had
declined while heroin use had remained fairly
stable.
■ One per cent of prisoners surveyed had
stopped using cannabis and started using
heroin since beginning their sentence, but
fear of detection by random testing was only
one factor affecting this behaviour.
■ Procedures for referrals to treatment following
a positive random test were under-used.
The overall conclusion reached by the study is that
MDT, along with other strategies, has substantially
reduced cannabis use within prisons but has had
little effect on the use of heroin. The study
suggests that prisoners know that heroin is less
easily detected than cannabis. If the objective of
MDT is to reduce heroin use in prison, this study
suggests that its impact will be minimal. A possible
reason for this, as the study concludes, is that
‘current use of heroin is more clearly influenced by
previous and persistent use … [and that] some
prisoners with a high level of dependence before
coming to prison are likely to be impervious to any
kind of sanction’.3 (Johnny Connolly)
1. Prison drug tests ‘failing to have impact’. The Scotsman, 22
April 2005.
2. Singleton N et al. (2005) The impact of mandatory drug
testing in prisons. Home Office Online Report 03/05.
www.homeoffice.gov.uk/rds/pdfs05/rdsolr0305.pdf 
For a summary of the findings see Home Office Research
Development and Statistics Directorate (2005) Findings 223
www.homeoffice.gov.uk/rds/pdfs05/r223.pdf
3. Findings 223, p.4.
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In 2002, the Department of Health and Children
requested the Methadone Prescribing
Implementation Committee to review the
Methadone Protocol that was introduced in
October 1998. The review was released in June
2005.1
According to the review, there were 6,883 people
receiving methadone treatment in Ireland at the
end of December 2003. 
As part of the review, submissions were invited
from interested parties and 46 submissions were
received in September 2002. The submissions were
analysed to identify themes, and recommendations
were made to address the themes identified. 
The themes and associated recommendations
were:
■ Breadth of representation on the
Methadone Prescribing Implementation
Committee A number of submissions
identified the need to invite representatives
from the community, service users, the
voluntary sector, the Drug Treatment Centre
Board, the former Area Health Boards and the
Irish Psychiatric Association on to the
committee. The committee will invite
representatives of the Drug Treatment Centre
Board, the former Area Health Boards and the
Irish Psychiatric Association to be represented
on the committee. 
■ Revising aspects of the regulations
Several submissions requested revisions to the
prescribing of methadone. None of these
suggestions were taken on board as it would
mean re-writing the regulations. 
■ Clients’ experiences of methadone
treatment services Clients attending
methadone treatment programmes requested
that all clients should participate in the
planning of their treatment, stable clients
should not need to attend weekly, individual
appointment times should be given to clients,
clients continuing to use drugs chaotically
should be treated separately from more stable
clients, and the issue of privacy with respect
to urinalysis should be addressed. The
committee recommended that it would be
more appropriate to address these issues
through the service users’ charter in each HSE
area. 
■ Issues pertaining to general practitioners
A number of submissions stated that there is
a need to take a co-ordinated approach to
methadone treatment outside the HSE
Eastern Region and to increase the
recruitment of level 1 and level 2 general
practitioners throughout the country. The
committee will review the role of the National
General Practitioner Co-ordinator to ensure
greater support to the areas outside the
Eastern Region. A small number of general
practitioners requested an increase in the
number of clients that a practitioner is
permitted to treat. The committee will deal
with such requests on an individual basis. It
was suggested that training on treating opiate
misuse be included in undergraduate and
postgraduate medical training. In addition, it
was suggested that specialist methadone
training should continue and that completion
of such training should be one of the criteria
for GMS posts in deprived areas. These ideas
were welcomed by the committee and will be
recommended to the relevant authorities. It
was also suggested that general practitioners
be given the resources to comply with the
requirements of the National Drug Treatment
Reporting System. Such compliance is a
condition of the general practitioners contract
negotiated in 2003. 
■ Issues pertaining to pharmacists
Pharmacists requested joint training with
other health professionals, which the
committee considered a useful suggestion.
The need to increase the recruitment of
pharmacists was raised. The committee
recommended the employment of a liaison
pharmacist for the HSE areas outside the
Eastern Region. Some pharmacists requested
routine hepatitis B vaccination; this is
available free from the HSE to all participating
pharmacists and their staff. Pharmacists and
clients raised the issue of security and privacy
in pharmacies. The committee reported that
these issues were outside their remit as they
had resource implications, and noted that
grants were available through the HSE for
upgrading premises. Some pharmacists
reported that a regular client might present
to a pharmacy without a prescription and the
pharmacists experienced a dilemma: to follow
the regulations, or to fulfil their duty of care
to the client. The committee took a
pragmatic view, stating that the pharmacist
should provide the previously prescribed
treatment, document the experience and
ensure the client sought an up-dated
prescription as soon as possible. Actions
should be taken to prevent its occurrence if
this practice is repeated on a regular basis. 
■ Co-ordination between services and
continuity of care for clients According to
the text of the submissions, the lack both of
co-ordination between psychiatric services
and drug treatment services and of continuity
of care between prison services and drug
treatment services needed to be addressed.
The committee agreed with these statements
and welcomed the establishment of a
national committee to develop protocols for
transfer of clients between the prison services
Review of the Methadone Treatment
Protocol 
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Methadone Treatment Protocol (continued)
Substance misuse in the HSE South
Eastern Area 
and the HSE. The committee stated that
structures should be developed to ensure that
clients on methadone treatment who require
psychiatric treatment are not at a
disadvantage. 
■ Guidelines for the management of young
drug users Guidelines for the management of
opiate users aged under 18 years were
requested; these will be provided by the
Department of Health and Children’s working
group in the near future. 
There were 19 recommendations in the
Methadone Protocol, of which 12 were completely
implemented by the end of 2004, four were
almost completely implemented and the
remaining three required some further work. The
three requiring further work related to service
provision, including the range of services, the link
between treatment services and general
practitioners, and pharmacists’ contracts. (Jean
Long)
1. Department of Health and Children (2005) Review of the
Methadone Treatment Protocol. Dublin: Department of Health
and Children. 
The Health Service Executive (HSE) South Eastern
Area published its annual report entitled Data co-
ordination overview of drug misuse 20041 in June
2005. The report comprises three sections:
treatment services, education and prevention, and
supply and control. 
Treatment services
This section analyses data collected from statutory
and voluntary drug and alcohol treatment agencies,
acute general hospitals and psychiatric hospitals
located in the HSE South Eastern Area. The data
from the drug and alcohol treatment services are
returned to the National Drug Treatment Reporting
System. The key findings reported are:
■ The total number of contacts with treatment
services increased by 80 per cent over a five-
year period, from 1,418 in 2000 to 2,549 in
2004 (Figure 1).1,2 Contacts with treatment
services include those by clients continuing in
treatment from the previous year, clients who
were assessed but not treated, clients who were
treated and concerned persons. The increase
over the five-year period was evident among
both male and female clients (Figure 1).
■ In 2004, 8 per cent of all clients treated in the
south-east were under the age of 18 years,
while 32 per cent of clients attending the
services were aged between 20 and 29 years.
■ Alcohol, followed by cannabis, were the most
common main problem substances for which
treatment was sought from 2000 to 2004
(Figure 2).
■ Of the clients who had used a drug, 40 per
cent reported that cannabis was the first drug
ever used.
■ In 2004, 32 per cent of clients did not report
using a secondary substance. The main
substances of secondary use were alcohol,
cannabis and ecstasy. 
■ In 2004, almost 60 per cent of clients treated
for alcohol and two-thirds of clients treated
for a drug as their main problem substance
were treated for the first time (Figure 3).
The total number
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treatment
services
increased by 80
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Substance misuse in the HSE South Eastern Area (continued)
■ In 2004, 111 (5%) cases had injected a
substance. Of those who had injected, 39
(31%) had shared injecting equipment.
■ In 2004, 151 concerned persons contacted
both statutory and non-statutory services in
the south-east. The majority of concerned
persons were female (78%).
■ Based on data received from the Hospital In-
Patient Enquiry (HIPE) Scheme: 
•  There were 2,155 cases admitted to acute
hospitals in the HSE South Eastern Area for
one of the following diagnoses:
- alcoholic psychosis
- drug psychosis
- alcohol dependence syndrome
- drug dependence
- non-dependent abuse of drugs.
•  Seventy-three per cent of treated cases
were male. 
•  In 2003, 28 per cent of all cases admitted
to an acute hospital for a drug- or alcohol-
related illness resided in Wexford. 
•  Over 70 per cent had a diagnosis of non-
dependent abuse of drugs and almost one-
fifth had a diagnosis of alcohol
dependence.
■ In 2003, the National Psychiatric In-Patient
Reporting System reported that there were
541 admissions with an alcohol disorder and
116 admissions with a drug disorder to a
psychiatric unit located in the HSE South
Eastern Area.
Education and prevention
Community-based drugs initiatives were set up in
the south-east to support local communities in
increasing their awareness of drug-related issues
and to assist in developing strategies to reduce the
demand for drugs in the community. There were a
total of 448 individual contacts with these services
in 2004. The majority of contacts (53%) were from
people concerned about someone else’s alcohol or
drug use.
Supply and control
The information in this section focuses on the 530
cases referred to the probation and welfare services
in the south-east for a drug- or alcohol-related
offence during 2004. Of these 530 cases: 
■ Eighty-six per cent were male.
■ Seven per cent were under 18 years and 62
per cent were aged between 18 and 29 years. 
■ Waterford had the highest percentage by
county, at 29 per cent.
■ The majority (56%) were referred because of
an alcohol-related offence.
Data presented in An Garda Síochána Annual Report
2003 indicate that 1,631 persons were prosecuted
for drugs offences in the south-east in 2003. This
represented 27 per cent of the national figures.
This overview is a comprehensive report that
examines in detail alcohol- and drug-related data
collected in the HSE South Eastern Area; such data
is useful for planning responses in the area. It is
recommended that other Health Service Executive
areas follow the example of the south-east and
publish such data on an annual basis. (Fionnola
Kelly and Jean Long)
1. Kidd M (2005) Data co-ordination overview of drug misuse
2004. Waterford: HSE South Eastern Area. 
2. Data for the years 2000 to 2003 from the annual Data 
co-ordination overview of drug misuse reports compiled by
M Kidd and published by the South Eastern Health Board
between 2001 and 2004. 
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Joint Oireachtas Committee report on
cocaine addiction
On 6 July 2005, the Joint Oireachtas Committee on
Arts, Sport, Tourism, Community, Rural and
Gaeltacht Affairs launched its seventh report
entitled The treatment of cocaine addiction, with
particular reference to the Irish experience.1
Cecilia Keaveney, TD and chair of the Joint
Committee, welcomed the audience to the launch
and thanked the authors of the report, Dr Siobhán
Barry, clinical director, and Ms Elizabeth Lawlor,
senior clinical psychologist, both of the Cluain
Mhuire Service. 
The report includes information on the
consequences of cocaine use, the usage of cocaine
in Ireland and the Irish experience of managing
cocaine addiction, and gives recommendations for
preventative strategies and evidence-based
treatment. According to the authors, lifestyles
associated with cocaine use include poor nutrition,
polysubstance use and criminality. The effects of
cocaine on the body are cumulative and may result
in fatal cardiovascular events. The report states that
suicide is the cause of death in up to 10 per cent of
cocaine-related deaths.
Irish patterns of cocaine use indicate:
■ Cocaine is used predominantly during early
adult life.
■ More males than females use cocaine.
■ There is increased availability and use of cocaine.
■ Cocaine use is not confined to the Dublin
region.
■ Data from the National Drug Treatment
Reporting System indicate that cocaine is
mainly reported as a second, third or fourth
problem drug for clients seeking treatment for
drug misuse.
A snapshot of the Irish experience of managing
cocaine addiction indicates:
■ Although the number of clients seeking
treatment who report cocaine as their main
problem drug has increased, the total number
is small. Clients do not seek treatment for one
of two reasons: either they do not perceive
themselves as requiring treatment or they
think existing treatment services are
inappropriate for their needs. This highlights
the challenge for the drug treatment services
to change what has historically been a
predominantly opiate-focused treatment
system into one that meets the needs of
cocaine and polydrug users. 
■ Many service providers are attempting to
provide some level of service for cocaine users,
which is increasing the pressure on existing
services.
■ Training on evidence-based treatment for
service providers is needed immediately.
In relation to treatment options, the authors
highlight the need for a holistic approach based on
the needs of the individual client. This involves
dealing with medical, psychological and social
problems and includes complementary therapies. 
Recommendations of the report include:
1. Preventative strategies, which embrace health
promotion, provide basic factual information and
offer specific psycho-education to expose the
misconceptions about cocaine.
2. A qualitative study of cocaine use identifying and
exploring the distinct needs of people who use
recreational cocaine and people who are
polysubstance users.
3. Resources to facilitate assessment for clients
presenting for treatment for problem cocaine use
which include:
basic physical assessment, including
cardiovascular screening
formal substance misuse assessment
psychological assessment, for example,
motivational interviewing
psychiatric assessment.
4. A pyramid of interventions comprising: 
drug-free outpatient care for clients who have
a relatively small cocaine use problem, at the
base 
a logical and sequential programme of
detoxification for clients addicted to a wide
range of substances, which includes
psychological care, social intervention, practical
education or occupational opportunities and
complementary therapies, as the second tier
residential after-care programmes of significant
duration which offer a wide range of
intervention to assist clients who are at
particular risk of relapse, at the apex. 
5. An outpatient-based, relapse-prevention
programme to which self-referral for those who
relapse would be encouraged.
Social reintegration was outside the scope of this
report. As chair of the Joint Committee, Cecilia
Keaveney outlined the committee’s present role as that
of seeking the allocation of resources to implement
the recommendations of this report. (Ena Lynn)
1. Joint Committee on Arts, Sport, Tourism, Community, Rural
and Gaeltacht Affairs (2005) The treatment of cocaine
addiction, with particular reference to the Irish experience.
Dublin: Stationery Office.
This publication can be purchased directly from
Government Publications Sales Office, Sun Alliance
House, Molesworth Street, Dublin 2, or by mail
order from Government Publications, Postal Trade
Section, 51 St Stephen’s Green, Dublin 2, Tel 01-
476834/35/36/37.
The effects of
cocaine on the
body are
cumulative and
may result in
fatal
cardiovascular
events.
In relation to
treatment
options, the
authors highlight
the need for a
holistic approach
based on the
needs of the
individual client.
20
drugnet
IRELAND
In March/April 2005 the Health and Safety Authority
conducted an Inspection Programme in Accident and
Emergency Units in selected Irish hospitals. The incidence
of violence faced by A&E workers in contact with people
in distress, including those suffering from alcohol or
substance abuse, was found to be high. This finding was
the subject of a Private Member's Motion in Dáil Éireann
on 10/11 May 2005. www.hsa.ie/www.oireachtas.ie
On 3 May 2005 the Special Residential Services Board
published a report on research into the impact of
placement in special-care-unit settings on the ‘well-
being’ of young people and their families. The majority
of young people placed in the special-care units had a
history of entrenched family difficulties and consequent
social and emotional problems placing them ‘at risk’,
which covered a wide range of behaviour and social and
emotional circumstances including drug use and misuse.
The report indicates that the approach in special care is
having a positive impact on children. www.srsb.ie
In May 2005 The Children’s Court: A Children’s Rights
Audit, based on a study of almost 1,000 cases in
Children’s Courts in Dublin, Cork, Limerick and
Waterford, was published. The report, by Dr Ursula
Kilkelly of the Faculty of Law, University College Cork,
concluded that in many cases the courts do not appear
to appreciate the complexity of the issues facing the
child, including substance abuse and alcohol and drug
addiction, and that detention is being increasingly used
because of a lack of support and early intervention for
young offenders. 
In May 2005 the World Health Organization (WHO)
released a Status Paper on Prisons, Drugs and Harm
Reduction. The paper summarises the evidence for
actions that will reduce the health-related harm
associated with drug dependence, indicating that harm
reduction measures can be safely introduced into
prisons, and that such measures help prevent the
transmission of HIV/AIDS. www.euro.who.int/
On 14 June 2005 Guidelines regarding drug dealing on or
in the vicinity of licensed premises were launched. Drawn
up by An Garda Síochána, members of the licensed
trade and the Department of Health and Children, this
publication was an initiative under the National Drugs
Strategy (Action 27).
At its 16–17 June 2005 meeting (10255/05 CONCL 2),
the European Council approved the EU Drugs Action
Plan (2005–2008). Noting with deep concern the
increase in the incidence of HIV/AIDS in the member
states, in neighbouring countries and worldwide, the
Council recalled the importance of active co-operation
between member states and the European Commission
to, among other things, improve access for intravenous
drug users to prevention, dependency treatment and
harm reduction services. www.europa.eu.int 
In June 2005 UNAIDS released a policy position paper
entitled Intensifying HIV Prevention. Regarding preventing
transmission of HIV through injecting drug use, the
policy calls for a comprehensive, integrated and effective
system of measures including the full range of treatment
options, the implementation of harm-reduction
measures, voluntary confidential HIV counselling and
testing, prevention of sexual transmission of HIV among
drug users, and access to primary healthcare and to
antiretroviral therapy. Such an approach is to be based
on promoting, protecting and respecting the human
rights of drug users. www.unaids.org/ 
On 1 July 2005 the commencement order for the
Safety, Health and Welfare at Work Act 2005 was
signed. The Act comes into force on 1 September 2005.
The provisions for testing employees for use of
intoxicants, including alcohol and/or drugs, will not
come into force until the Health and Safety Authority has
consulted the Social Partners and other interested
groups. The regulations governing testing will bring in
the requirement in safety-critical situations and then only
on a sectoral basis. www.hsa.ie 
On 22 July 2005 the Irish Society for the Prevention of
Cruelty to Children (ISPCC) launched a new strategy
entitled Citizen Child. The strategy sets out five targets in
response to what are identified as the key changes and
challenges in Irish society impacting on childhood,
including alcohol and drug misuse owing to growing
social isolation, family dysfunction and personal
emotional and psychological difficulties. www.ispcc.ie 
On 25 July 2005 the third Annual Government Progress
Report on the Implementation of the Programme for
Government was published. It reports on drug-related
measures under four headings: Building an Inclusive
Society, Crime, Tackling Drug Abuse, and Regenerating
Disadvantaged Communities. www.taoiseach.gov.ie 
In July 2005 Eurobarometer 63, the most recent issue in a
series reporting on a twice-yearly survey of public opinion
in the European Union, for which the field work was
conducted in May/June 2005, was published. Asked to
select the three actions that the EU should follow, in order
of priority, from a list of 16 possible actions, the aggregate
response from the 25 member states showed that
‘fighting organised crime and drug trafficking’ was ranked
fourth, after ‘fighting unemployment’, ‘fighting poverty
and social exclusion’ and ‘maintaining peace and security
in Europe’. UK respondents ranked ‘fighting organised
crime and drug trafficking’ as the top priority for action;
respondents in Ireland, Cyprus and Estonia ranked it
second, after ‘fighting poverty and social exclusion’. The
Irish ranking shows a change from the results reported in
Eurobarometer 62, for which the field work was conducted
in October/November 2004. On that occasion Irish
respondents ranked ‘fighting organised crime and drug
trafficking’ as the top priority for action, just ahead of
‘fighting poverty and social exclusion’.
http://europa.eu.int/comm/public_opinion/index_en.
htm 
(Compiled by Brigid Pike)
In brief 
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For researchers, drug treatment professionals,
clinicians, community workers, policy makers and
students, keeping informed on current trends and
thinking in the broad subject area of drug and
alcohol addiction can be time consuming and
difficult, particularly for those without direct access
to a well resourced research library.
The National Documentation Centre on Drug Use
(NDC) holds a collection of approximately 30
academic journals, magazines and newsletters that
will be of interest to the various professionals in
the field. The collection represents both national
and international research and opinion on the
subject of drug and alcohol use, prevention,
treatment, education and social consequences. The
range of journals reflects the points of view of a
wide variety of disciplines, such as: medicine, social
science, psychology, public health and nursing.
The NDC collection continues to grow, reflecting
the changing and expanding needs of NDC users. 
The National Documentation Centre
journal collection
Addiction
Addictive Behaviors
Addiction Research & Theory
Alcohol and Health: Current Evidence
Archives of General Psychiatry
British Medical Journal
Drug and Alcohol Dependence
Drug & Alcohol Findings
Drug and Alcohol Review
Drink and Drugs News
Druglink
Drugs – Education Prevention and Policy
European Addiction Research
Drugs in Focus
EPI Insight 
Eurosurveillance Weekly
Fesat – European Foundation of Drug Help
Lines Newsletter
Harm Reduction Journal
Hyper 
International Journal of Drug Policy
Irish Journal of Medical Science
Irish Journal of Psychological Medicine
Irish Medical Journal
Journal of Addiction Nursing (from Jan 2006)
Journal of Epidemiology & Community Health
(from Jan 2006) 
Journal of Substance Abuse Treatment
Journal of Drug Issues
The Lancet
MMWR Morbidity & Mortality Weekly
New England Journal of Medicine
Poverty Today
Psychological Medicine
NDC Journal Collection
Some of the leading journals and newsletters
include: 
Addiction – (formerly British Journal of Addiction) a
well known peer-reviewed journal in print since
1947. It publishes high-quality international
research for a large readership, with editorials,
commentaries, interviews with leading figures in
the field, and a comprehensive book review section.
Druglink – a bi-monthly magazine for
professionals interested in drugs and drug-related
issues in the UK. Druglink includes current news,
feature articles, interviews, factsheets, and reviews
and covers topics such as treatment, public health,
education and prevention, criminal justice and
international issues.
Drugs: Education, Prevention & Policy – a peer-
reviewed journal which provides a forum for
communication and debate between policy
makers, practitioners and researchers concerned
with social and health policy responses to legal
and illicit drug use and drug-related harm. This
journal has published Irish drug-related research
and includes Dr Shane Butler, TCD, and Dr Mark
Morgan, St. Patrick's College Drumcondra, on its
editorial board.
European Addiction Research – a unique
international forum for the exchange of
interdisciplinary information and expert opinion on
all aspects of addiction research. The journal’s
broad scope and cross-cultural perspective reflect
the importance of a comprehensive approach to
resolving the problems of substance abuse and
addiction in Europe. Coverage ranges from clinical
and research advances in the fields of psychiatry,
biology, pharmacology and epidemiology to the
social and legal implications of policy decisions. In
recent years this journal has published Irish drug-
related research.
Harm Reduction Journal – a new online journal
that provides free access to peer-reviewed research
and focuses on prevalence of psychoactive drug
use, public policy, harm reduction, public health,
and the social consequences associated with drug
use and drug policies, in particular changing
patterns of drug use and their implications for the
spread of HIV / AIDS and other bloodborne
pathogens.
International Journal of Drug Policy – provides a
forum for the dissemination of current research,
reviews, debate, and critical analysis on drug use
and drug policy in a global context. It seeks to
publish material on the social, political, legal, and
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health contexts of psychoactive substance use, both
licit and illicit. The journal is particularly concerned
to explore the effects of drug policy and practice
on drug-using behaviour and its health and social
consequences. This journal has published Irish
drug-related research in recent years.
Of Substance – The national magazine on
alcohol, tobacco and other drugs – an Australian
magazine for the drug, alcohol and tobacco and
other drugs sector (ATOD). Funded by the
Australian Department of Health and Ageing, the
magazine’s target audience is the frontline ATOD
workforce in Australia. The magazine is also aimed
at policy makers, academics and others interested
in ATOD issues. The magazine’s main purpose is to
disseminate current research and best practice to
the ATOD field in plain English. 
Substance Use & Misuse – publishes peer-
reviewed research and provides an international
and multidisciplinary environment for the
exchange of facts, theories, opinions, and issues
concerning substance use and misuse of licit and
illicit drugs, alcohol, nicotine, and caffeine. The
journal also addresses issues around eating
disorders and gambling.
New Service
Keeping informed of current research and best
practice is an important part of professional
development. Drug sector workers and others with
an interest in drugs and alcohol issues can inform
themselves by reading some of the many journals
and newsletters available in the NDC.
Visitors to the NDC library are welcome to browse
the journal collection during opening hours.
However, to accommodate our nationally
dispersed users, the NDC has also put in place an
‘Alert Service’ for users who cannot visit the library
on a regular basis or those who prefer to receive
electronic content. (Louise Farragher)
If you would like to receive the tables of
contents of selected journals, newsletters
or magazines via email on a regular
basis, please email Louise Farragher,
Information Specialist in the NDC,
(louise@hrb.ie) and ask for a ‘Table of
Contents Request Form.’ When you
complete and return this form, we will
send the tables of contents of your
selected journals to your email address
on a regular basis.
The National Documentation Centre on
Drug Use is funded by the Department
of Community, Rural and Gaeltacht
Affairs under the National Development
Plan 2000–2006
The National Documentation Centre journal collection (continued)
Recent publications
Books
Corporate social responsibility and alcohol: the
need and potential for partnership
Grant M and O’Connor J (eds) 
Routledge 2005, pp. 224.
ISBN 0 415 94948 3
This is the eighth book in the International Center
for Alcohol Policies (ICAP) series on alcohol in
society. ICAP is a not-for-profit organisation funded
by ten international alcohol companies, some of
which have contributed to this volume. The book
is co-edited by Joyce O’Connor, president of the
National College of Ireland, who has served as
chair of the World Health Organization expert
committee on alcohol and the workplace.
This book advances the debate on the rights and
responsibilities of those involved in developing
alcohol policies by exploring the relationship
between alcohol, ethics and corporate social
responsibility (CSR). CSR involves a broad
commitment by companies to social welfare and
the common good and to the policies that support
them. This volume examines the need and
potential for CSR in the beverage alcohol industry
and discusses the issues involved in terms of
alcohol policy, public–private partnership, public
health perspectives and government regulation. A
number of chapters focus on CSR as applied to the
advertising of alcohol and its promotion to young
people, setting standards for responsible consumer
marketing, and developing solutions for abusive
drinking on campus. Further chapters present
examples of practices to be encouraged and
avoided, successful alcohol education programmes,
and guidelines for responsible action and
commitment to positive values already inherent in
the industry. Each chapter is followed by a
comprehensive list of references and the book has
an eight-page index.
Substance misuse in pregnancy: a resource book
for professionals
2nd edition, DrugScope 2005, pp. 128.
ISBN 1904319 351
Based on an original publication by the Lothian
Health Board in 2003, this book aims to establish a
‘framework for care’ so that all women who use
drugs can be offered appropriate support before,
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during and after the birth of their child. Described
as a ‘resource pack’ the book is directed at GPs,
nurses, midwives, drug workers, health visitors,
social workers and students from all disciplines.
While the book takes a broad view of drug use that
includes alcohol and nicotine, it refers mainly to
the care of women who have significant problems
related to drug and alcohol use. Social and lifestyle
factors often complicate the delivery of care to
these women, and much co-ordination and
understanding between services is needed. 
The opening chapters give a concise listing of key
points, a description of the nature and extent of the
problem, and an outline of the ‘philosophy of
approach’. Written in jargon-free language by
professionals in the field, the book discusses and
provides information and intervention strategies on
issues such as pre-conception care, the management
of substance use in pregnancy, substitute
prescribing, breastfeeding and Neonatal Abstinence
Syndrome (NAS). The information and advice is
based on current best practice and available
evidence. The appendices comprise 11 information
leaflets (useful templates that can be adapted by any
service) that aim to improve liaison among the
professionals involved as well as acting as a valuable
source of information for the service user. 
Druglink guide to UK drug policy
Baker B (text), Shapiro H (ed) DrugScope 2004, pp.
115 
ISBN 1904319181
This is the first edition of a unique publication that
details the history of the UK drug strategy and
explains current initiatives in each of the key areas
identified in the Updated Drug Strategy (2002). The
book aims to clarify the complex matrix of activity,
involving an array of networks, partners, initiatives
and funding streams at local, regional and central
levels (with a bewildering set of acronyms and
initials), that has developed in the UK drugs field in
the past ten years. 
A three-page commentary on the evolution of UK
drugs policy introduces the book. The first chapter
gives a concise overview, in tabular format, of key
events and significant documents from the setting
up of the task force to review services for drug
misusers in April 1994 to the re-classification of
cannabis in January 2004. The next chapter gives
the detail behind these events and documents,
tracing the changes in approach and the switching
of responsibilities between departments and
agencies as the government attempted to develop
a unified strategy with a linked approach. The next
chapter attempts to explain the complex ways in
which the 2002 updated strategy is organised and
the responsibilities for its various elements, and
outlines current developments in key areas. The
drug strategies of Scotland, Wales and Northern
Ireland are outlined. A summary analysis presents
the pros and cons of the current strategy and
points to some major challenges facing it. A
comprehensive 50-page glossary lists and explains
the broad range of agencies, networks and
initiatives involved. 
Journal articles 
The following abstracts are from a selection of
articles relating to the drugs situation in Ireland
recently published in international journals. 
MDMA and sexual behaviour: ecstasy users'
perceptions about sexuality and sexual risk
McElrath K
Substance Use & Misuse 2005; 40 (9–10):
1461–1477
This study examines the relationship between
MDMA (Ecstasy), sexual behaviour, and sexual risk
taking. The sample consisted of 98 current and
former users of MDMA. Several strategies were
utilised to recruit respondents and data were
collected through in-depth interviews during 1997
and 1998. The majority of respondents had used
MDMA during the six-month period prior to the
interview and a large percentage had consumed
the drug on 100 occasions or more. Most
respondents reported feelings of emotional
closeness while consuming MDMA but without the
desire for penetrative sex. Others, however,
reported that MDMA increased sexual arousal and
some respondents (in particular, gay and bisexual
females) had used MDMA specifically for sexual
enhancement. Sexual risk taking (e.g., having
multiple partners, engaging in sex without a
condom) was prevalent among respondents who
did engage in sexual activity during MDMA
episodes. Explanations for the findings are offered
and implications for prevention and intervention
are discussed.
Neurocognitive insights into substance abuse
Garavan H and Stout JC
Trends in Cognitive Sciences 2005; 9(4): 195–201
Cognitive studies are revealing key aspects of how
drug abusers monitor and respond to negative
feedback differently from non-abusers, and in doing
so are adding an important piece to the conceptual
puzzle that must be solved to understand, treat,
and prevent drug abuse. In this review, the authors
bring together two quite different lines of research,
one addressing the selection of gambles in a risky
decision task, and the other focused on imaging
neural systems related to the detection and
processing of errors. The authors suggest that
diminished behavioural control, which is a cardinal
feature of drug abuse, may be linked to alterations
in the psychological and neural mechanisms that
detect error signals and which, in turn, lead to
optimisation of behavioural responses. 
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The Irish Affected Sib Pair Study of Alcohol
Dependence: study methodology and validation
of diagnosis by interview and family history
Prescott CA, Sullivan PF, Myers JM, Patterson DG,
Devitt M, Halberstadt LJ, Walsh D and Kendler KS
Clinical & Experimental Research 2005; 29(3):
417–429 
This article is the first report of the Irish Affected
Sib Pair Study of Alcohol Dependence, whose goal
is to detect the genomic location of susceptibility
loci for alcohol dependence (AD). This article
describes phenotypic characteristics of the
probands, siblings, and parents included in the
sample and examines agreement among different
sources of diagnostic information, including the
validity of family history (FH) assessment. The
authors concluded that individuals with AD were
able to provide accurate evaluations of alcoholism
symptoms in their parents and adult siblings. A
single screening item performed nearly as well as
the full scale. Collecting information from multiple
informants may not be cost effective for the gain
in predictive accuracy. FH information collected
from affected informants can be a valuable source
of diagnostic information for family studies of
alcoholism.
Bloodborne virus infections among drug users
in Ireland: a retrospective cross-sectional survey
of screening, prevalence, incidence and
hepatitis B immunisation uptake
Grogan L, Tiernan M, Geoghegan N, Smyth B and
Keenan E
Irish Journal of Medical Science 2005; 174(2): 14–20
Injecting drug users are at high risk of bloodborne
viral infections, including hepatitis C (HCV),
hepatitis B (HBV) and HIV. The aim of this article is
to document screening for and immunisation
against bloodborne viruses and to determine the
known prevalence and incidence of these
infections. The authors conducted a cross-sectional
survey of clients attending 21 specialist addiction
treatment clinics in one health board area in
greater Dublin. Data were collected on
demographic characteristics, serology for HCV,
HBV and HIV and immunisation against HBV. The
authors conclude that the proportion of clients
screened for HCV, HBV and HIV infection has
increased since the introduction of a screening
protocol in 1998. Targeted vaccination against
hepatitis B for opiate users is more successful than
previously shown in Ireland. The prevalence and
incidence of bloodborne viruses remains high
among opiate users attending addiction treatment
services, despite an increase in availability of harm
reduction interventions.
Patient-controlled benzodiazepine dose
reduction in a community mental health service
Bangaru R and Meagher D
Irish Journal of Psychological Medicine 2005; 
22(2): 42–45 
This article details a patient-controlled
benzodiazepine discontinuation programme in a
generic multidisciplinary community mental health
service. A prescribing audit identified suboptimal
benzodiazepine use which stimulated a
discontinuation programme (prescribing policy,
psycho-education, anxiety management) to
encourage benzodiazepine cessation.
Benzodiazepine status was re-assessed at 12- and
24-month follow-ups. Benzodiazepine status at
follow-up was predicted by attendance at anxiety
management sessions and shorter duration of
benzodiazepine use. Patients attending anxiety
management sessions were 2.5 times more likely
to reduce use. Discontinuation followed four
patterns: (a) rapid and complete discontinuation (n
= 19); (b) total discontinuation in a gradual
manner (n = 13); (c) partial dose reduction
without total discontinuation (n = 18) and (d)
almost total discontinuation with continued low-
dose use (n = 8). The patients who achieved total
discontinuation were younger and in receipt of
benzodiazepine agents for a shorter duration. At
24-month follow-up only three patients had
relapsed into benzodiazepine use and a further 13
had achieved total discontinuation. The authors
conclude that many chronic benzodiazepine users
can achieve lasting discontinuation with patient-
controlled dose tapering. Patient refusal and
service dropout are common during
discontinuation programmes. Anxiety
management is a valuable adjunct to
discontinuation.
Methylenedioxymethamphetamine suppresses
production of the proinflammatory cytokine
tumor necrosis factor-alpha independent of a
beta-adrenoceptor-mediated increase in
interleukin-10
Connor TJ, Harkin A and Kelly JP
Journal of Pharmacology & Experimental Therapeutics
2005; 312(1):134–43 
Recent data suggest that 3,4-
methylenedioxymethamphetamine (MDMA;
‘Ecstasy’) has marked immunosuppressive
properties. In this study, we investigate the effect
of MDMA on production of the anti-inflammatory
cytokine interleukin (IL)-10 in response to an in
vivo challenge with bacterial lipopolysaccharide
(LPS). Our data demonstrate that both acute and
repeated administration of MDMA increases
production of LPS-induced IL-10 in vivo, and this
increase correlates inversely with the ability of
MDMA to suppress the proinflammatory cytokine
tumor necrosis factor (TNF)-alpha. Despite this
correlation, immunoneutralization of IL-10 does
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not reverse the suppressive effect of MDMA on
LPS-induced TNF-alpha production, indicating that
suppression of this proinflammatory cytokine is not
mediated by IL-10. In vitro exposure to MDMA
does not mimic the immunosuppressive cytokine
phenotype induced in vivo, suggesting that these
immunosuppressive effects are not mediated by a
direct action on monocytes per se. As MDMA
activates that hypothalamic pituitary adrenal axis
and sympathetic nervous system, we examined the
role of glucocorticoids and catecholamines in its
immunosuppressive actions. However, the
immunosuppressive cytokine phenotype induced
by MDMA was not altered by adrenalectomy,
sympathetic denervation, or ganglionic blockade,
indicating that neither glucocorticoids nor
adrenal/sympathetic-derived catecholamines
mediate these immunosuppressive effects of
MDMA. Interestingly, beta-adrenoceptor blockade
completely inhibited the increase in IL-10 induced
by MDMA without altering the suppression of
TNF-alpha. Taken together, these data demonstrate
a role for beta-adrenoceptor activation in the
ability of MDMA to increase LPS-induced IL-10 and
highlight a mechanistic dissociation between the
ability of MDMA to increase IL-10 and suppress
production of the proinflammatory cytokine TNF-
alpha.
Experience of hepatitis C among current or
former heroin users attending general practice
Cullen W, Kelly Y, Stanley J, Langton D and Bury G
Irish Medical Journal 2005; 98(3):73–4
The majority of injecting drug users in Ireland are
infected with hepatitis C (HCV) and many attend
general practice for methadone maintenance
treatment. To describe awareness and experience
of HCV infection, related investigations and
treatment, a semi-qualitative interview study of
current or former heroin users attending a general
practice was carried out. Twenty-five patients (69%
of total) were interviewed, of whom 23 were on
methadone maintenance therapy at the time of
the interview and 22 were HCV positive. While
awareness of harm reduction measures and health
implications of the infection was good, continued
high-risk activity was common. Negative
experiences of diagnosis, of subsequent
investigations and of treatments received were
common. Only one person had been treated for
HCV. We conclude that there are a number of
barriers to effective HCV management among
heroin users and that further research is needed to
improve our understanding of this issue.
Cocaine dependence and attention switching
within and between verbal and visuospatial
working memory
Kubler A, Murphy K and Garavan H
European Journal of Neuroscience 2005;
21(7):1984–92
Many studies have shown the negative effects of
cocaine on neuropsychological and cognitive
performance in drug-dependent individuals, but
little is known about the underlying neuroanatomy
of these dysfunctions. The present study addressed
attention-switching between items held in working
memory (WM) by means of a task in which
subjects were required to store and update two
items held in verbal or visuospatial WM. Attention-
switching frequency varied between trials, thereby
allowing us to isolate the switching component of
task performance. Behavioural data revealed that
cocaine addicts performed worse than healthy
controls in all tasks. On the visuospatial task,
addicts performed at chance levels revealing
particular impairment in visuospatial WM. On the
verbal task, in which controls and users could be
matched for performance, we identified attenuated
responses in prefrontal and cingulate cortices and
in striatal regions, while other areas such as
dorsolateral prefrontal cortex did not differ
between healthy controls and users. The results
reveal that addiction may be accompanied by
specific rather than ubiquitous hypoactivation in
prefrontal and subcortical areas and suggest a
compromised ability in users to control their
attention to their thoughts as might be particularly
relevant when required to switch away from drug-
related thoughts, and thus the dysfunction in
attention-switching may contribute to the
maintenance of addiction. 
(Compiled by Joan Moore and Louise Farragher)
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29 September 2005
Mapping, Analysing and Tackling Drug Markets 
Venue: Central London (Tbc)
Organised by / Contact: Policy Spotlight Ltd
6th Floor, Portland House, Stag Place
London SW1E 5RS, UK
Tel: +44 (0) 870 351 8720
Fax: +44 (0) 870 351 8721
www.policyspotlight.co.uk
Information: Since the publication of the UK
National Drug Strategy, considerable progress has
been made on increasing treatment provision,
improving drug education and tackling drug-
related crime. However, there has been less success
in reducing the overall level of drugs available in
the UK. This conference seeks to stimulate positive
responses to tackling the supply of drugs and deal
with the dealers. Combining presentations from
researchers and practitioners, it sets out a number
of key challenges for those involved in trying to
reduce the availability of illegal drugs.
29 September 2005
School and Family-based Programmes for
Preventing Substance Misuse. Addiction Research
Centre 5th Annual Conference
Venue: Edmund Burke Theatre, Arts Building,
Trinity College Dublin
Organised by / Contact: Fiona Clarke, Addiction
Research Centre, M45 Goldsmith Hall, Trinity
College Dublin
Tel: + 353 (0) 1 608 3647
Fax: + 353 (0) 1 608 3790
Information: This year’s conference is intended to
offer participants from a range of backgrounds the
opportunity to reflect on this theme, to
acknowledge and engage with the complexity of
the issues, and to see how in practical terms we
can make progress in reducing the prevalence of
drug and alcohol problems in Irish society.
October
13–15 October 2005
Habits of a Lifetime: Habits and behaviours in
addictions over the past 25 years, the past,
present and future. Elisad (European Association of
Libraries and Information Services on Alcohol and
other Drugs) 17th Annual Conference
Venue: Oslo, Norway
Organised by / Contact: Brian Galvin, National
Documentation Centre on Drug Use, Holbrook
House, Holles Street, Dublin 2, Ireland
Tel: +353 (0) 1 676 1176 ext 168 
Fax: +353 (0) 1 661 8567
Email: bgalvin@hrb.ie
Information: Specialists from Norway and
elsewhere will give an overview of trends relating
to drugs, alcohol and smoking and their impact
upon everyday matters such as driving, the
workplace, and communicable diseases such as
hepatitis C. Planned workshops on information
issues include: access to electronic journals, the
role of the information specialist in a virtual
environment, a review of addiction databases and
resources and an update on Elisad’s activities.
14 October 2005
National Conference on Injecting Drug Use
Venue: Victoria Park Plaza Hotel, London
Organised by / Contact: Monique Tomlinson
Tel: +44 (0) 20 7928 9152
Email: info@exchangesupplies.org
www.exchangesupplies.org
Information: Key topics covered will include:
injecting injuries and wound care: causes and
treatment; increasing coverage; outreach, mobile
and peer-delivered services; injecting rooms and
working with injectors of performance-enhancing
drugs.
22 October 2005 
Drugs: Issues and Experiences
Venue: All Hallows College, Dublin
Organised by / Contact: Community Awareness
of Drugs (CAD)
Cost: €60 (includes course materials, lunch and
refreshments). To reserve a place, send €20 non-
refundable deposit to CAD by 17 October.
Tel: +353 (0) 1 679 2681 
Email: communityawareness@eircom.net
Information: This one-day training event will be of
interest to public sector, community and youth
workers concerned with addiction issues. It will
provide a thorough introduction to substance
misuse – the effects and risks, drug-use patterns
and emerging trends – with practical examples of
brief interventions that can be used in a variety of
settings. Principal speakers are Dr Des Corrigan
(chair of the National Advisory Committee on
Drugs) and Paul Delaney (Centre of Achievement
in Motivation). There will also be an opportunity to
hear from young people in recovery and
representatives from family support groups, who
will share their personal experiences.
Upcoming events
27
drugnet
IRELAND
Upcoming events (continued)
23–28 October 2005
48th International ICAA Conference on
dependencies: Science, Politics and the
Practitioners
Venue: Corinthia Royal Grand Hotel, Budapest
Organised by / Contact: International Council on
Alcohol and Addictions
www.icaa.hu
Information: The International Council on Alcohol
and Addictions (ICAA) is a non-governmental
organisation. This event coincides with the 100th
anniversary of the Tenth International Congress
Against Alcoholism which was held in Budapest in
1905 and which set the stage for the founding of
ICAA in 1907. The conference provides a unique
opportunity to meet and exchange views with
international experts as well as with delegates from
around the world. The programme covers the
entire field of the addictions, with plenary sessions
featuring leading scholars, and hundreds of
learned papers from speakers representing some
22 sections of ICAA.
27–29 October 2005
16th Annual Conference of the European
Society for Social Drug Research (ESSD)
Venue: Manchester
Organised by / Contact: Jane Fountain or Dirk
Korf, c/o DrugScope, 32–36 Loman Street, London
SE1 OEE
Tel: +44 (0) 20 7928 1211
Fax: +44 (0) 20 7922 8780
Email: JFountain1@uclan.ac.uk, korf@jur.uva.nl
Information: This year's conference themes are:
methodological perspectives in drug research;
trends and patterns in drug use; drug distribution;
drug use and crime; and concept analysis of the
drugs discourse.
November
7 November 2005
Annual Drug and Alcohol Professionals
Conference
Venue: London (Royal Institute of British
Architects)
Organised by / Contact: Federation of Drug &
Alcohol Professionals
Tel: +44 (0) 870 763 6139
Email: office@fdap.org.uk
www.fdap.org.uk
Information: At this year's annual Drug and
Alcohol Professionals Conference, front-line
workers, line managers and commissioners will
have the chance to attend practice-focused
workshops and seminars on a wide range of policy
and practice issues, hear from leading figures
about the likely future of drug and alcohol use and
related-services, and have their say on some of the
major issues facing workers in the field.
16–18 November 2005
The 9th International Hepatitis C Conference:
Pushing Perceptions to Challenge Prevention,
Treatment and Care
Venue: Mercure Hotel Berlin, 
Tempelhof Airport, Berlin
Organised by / Contact: Mainliners, UK Hepatitis
C Resource Centre, 195 Old Kent Road, London
SE1 4AG
Tel: +44 (0) 20 7378 5495. 
Email: hepcconf@mainliners.org.uk 
www.hepccentre.org.uk/INThcv.htm
Information: This year’s International Hep C
Conference is being held in Berlin during German
Liver Week. It will debate current thinking and
challenge future practice in relation to hepatitis C
prevention, testing and treatment. Workshops will
focus on risk groups, access to treatment and how
to engage and retain individuals in care, to
produce a series of international conference
recommendations in each area.
17–18 November 2005 
Society for the Study of Addiction: Annual
Symposium 2005. If we did have evidence-
based policy and practice, what would they look
like?
Venue: York Viking Moat House Hotel, York
Organised by / Contact: Paula Singleton, Society
for the Study of Addiction, Leeds Addiction Unit
Tel: +44 (0) 113 295 1315
Fax: +44 (0) 113 295 2789
Email: p.singleton@nhs.net
www-users.york.ac.uk/~sjp22/addiction/index.htm
Information: What does the evidence tell us about
policy and practice? This conference will address
issues of evidence-based policy and practice. It will
pose such questions as: What do governments
have in their power to do to reduce alcohol-, drug-
and tobacco-related harm? Why don't they take
these actions?
December
7 December 2005
Something in the mind: drugs and the mental
health of young people
Venue: Austin Court, Birmingham
Organised by / Contact: Pavilion conferences
Tel: +44 (0) 1273 623 222
Email: info@pavpub.com
www.pavpub.com
Information: The debate over cannabis is only one
example of much wider concerns about the effects
of drugs and the mental health of young people.
Yet it is the physical and social effects of drugs
misuse that grab the attention of the media, public
and politicians.
This conference will feature plenaries on policy
issues and workshops looking at good practice.
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January – March 2006
Employee Drug Testing – Complying with the
Safety, Health & Welfare at Work Act 2005
Thursday 19 January 2006 
Venue: Stillorgan Park Hotel, Dublin 
Thursday 2 February 2006 
Venue: Clarion Hotel, Limerick
Thursday 2 March 2006 
Venue: Radisson Hotel, Cork 
Organised by / Contact: Caroline Cahill, EAP
Institute, 143 Barrack Street, Waterford.
Tel: +353 (51) 855733
Fax: +353 (51) 879626
Email: eapinstitute@eircom.net 
March 2006
9–10 March 2006
2006 National Drug Treatment Conference
Venue: UK, to be announced
Information: Five major themes will be addressed
by the conference: Marginalised groups; Key
clinical issues; Prison healthcare; Commissioning;
Pharmacy services.
Call for papers:
Papers and ideas for presentations are welcomed.
We invite prospective delegates to submit short
papers relevant to the conference themes.
Submissions may be accepted for either oral paper
presentations or poster displays. All abstracts will
be peer reviewed and judged on their relevance to
the conference. The deadline for abstracts is 
1 December 2005. All received abstracts will be
acknowledged by return e-mail within two working
days. Please send submissions to
monique@exchangesupplies.org
(Compiled by Louise Farragher)
Drugnet Ireland mailing list
If you wish to have your name included on
the mailing list for future issues of Drugnet
Ireland, please send your contact details to
the Administrative Assistant, Drug Misuse
Research Division, Health Research Board,
Holbrook House, Holles Street, Dublin 2. 
Tel: 01 676 1176 Ext 127; Email: dmrd@hrb.ie
Please indicate if you would also like to be
included in the mailing list for Drugnet Europe
and Drugs in focus.
The documents referred to in this issue of
Drugnet Ireland are available in the National
Documentation Centre on Drug Use at the
above address. Tel: 01 676 1176 Ext 175;
Email ndc@hrb.ie
The Drug Misuse Research Division (DMRD)
of the Health Research Board is a multi-
disciplinary team of researchers and
information specialists who provide objective,
reliable and comparable information on the
drug situation, its consequence and responses
in Ireland. The DMRD maintains two national
drug-related surveillance systems and is the
national focal point for the European
Monitoring Centre for Drugs and Drug
Addiction. The Division also manages the
National Documentation Centre on Drug Use.
The DMRD disseminates research findings,
information and news through its quarterly
newsletter, Drugnet Ireland, and other
publications. Through its activities, the DMRD
aims to inform policy and practice in relation
to drug use.
